<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=ks_c_5601-1987">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List
href="Moderna-v-Pfizer-DCT-Claim-Construction_files/filelist.xml">
<link rel=Edit-Time-Data
href="Moderna-v-Pfizer-DCT-Claim-Construction_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:CustomDocumentProperties>
  <o:Created dt:dt="date">2023-08-03</o:Created>
  <o:LastSaved dt:dt="date">2023-08-06</o:LastSaved>
 </o:CustomDocumentProperties>
</xml><![endif]-->
<link rel=themeData
href="Moderna-v-Pfizer-DCT-Claim-Construction_files/themedata.thmx">
<link rel=colorSchemeMapping
href="Moderna-v-Pfizer-DCT-Claim-Construction_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:DrawingGridHorizontalSpacing>5.5 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>KO</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:ULTrailSpace/>
   <w:ShapeLayoutLikeWW8/>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DoNotOptimizeForBrowser/>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;
	mso-font-alt:Georgia;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-alt:"Microsoft Sans Serif";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-452972801 -1073717157 41 0 66047 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:none;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:.05pt;
	margin-right:147.65pt;
	margin-bottom:0in;
	margin-left:146.9pt;
	text-align:center;
	mso-pagination:none;
	mso-outline-level:1;
	text-autospace:none;
	font-size:14.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-font-kerning:0pt;
	mso-fareast-language:EN-US;}
h2
	{mso-style-priority:9;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:39.95pt;
	line-height:15.85pt;
	mso-line-height-rule:exactly;
	mso-pagination:none;
	mso-outline-level:2;
	text-autospace:none;
	font-size:14.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin:0in;
	mso-pagination:none;
	text-autospace:none;
	font-size:14.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:94.0pt;
	text-indent:-18.05pt;
	mso-pagination:none;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-fareast-language:EN-US;}
p.TableParagraph, li.TableParagraph, div.TableParagraph
	{mso-style-name:"Table Paragraph";
	mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin:0in;
	mso-pagination:none;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	mso-fareast-language:EN-US;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:0pt;
	mso-ligatures:none;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	mso-pagination:none;
	text-autospace:none;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") fcs;
	mso-endnote-separator:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") es;
	mso-endnote-continuation-separator:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") ecs;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 14.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:0in;
	mso-page-numbers:1;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h2;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f2;
	mso-paper-source:0;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-page-numbers:3;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h3;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f3;
	mso-paper-source:0;}
div.WordSection3
	{page:WordSection3;}
@page WordSection4
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h4;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f4;
	mso-paper-source:0;}
div.WordSection4
	{page:WordSection4;}
@page WordSection5
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h5;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f5;
	mso-paper-source:0;}
div.WordSection5
	{page:WordSection5;}
@page WordSection6
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h6;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f6;
	mso-paper-source:0;}
div.WordSection6
	{page:WordSection6;}
@page WordSection7
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h7;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f7;
	mso-paper-source:0;}
div.WordSection7
	{page:WordSection7;}
@page WordSection8
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 68.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:58.05pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h8;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f8;
	mso-paper-source:0;}
div.WordSection8
	{page:WordSection8;}
@page WordSection9
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h9;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f9;
	mso-paper-source:0;}
div.WordSection9
	{page:WordSection9;}
@page WordSection10
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 68.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:58.05pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h10;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f10;
	mso-paper-source:0;}
div.WordSection10
	{page:WordSection10;}
@page WordSection11
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h11;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f11;
	mso-paper-source:0;}
div.WordSection11
	{page:WordSection11;}
@page WordSection12
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h12;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f12;
	mso-paper-source:0;}
div.WordSection12
	{page:WordSection12;}
@page WordSection13
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h13;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f13;
	mso-paper-source:0;}
div.WordSection13
	{page:WordSection13;}
@page WordSection14
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h14;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f14;
	mso-paper-source:0;}
div.WordSection14
	{page:WordSection14;}
@page WordSection15
	{size:8.5in 11.0in;
	margin:25.0pt 31.0pt 67.0pt 32.0pt;
	mso-header-margin:11.6pt;
	mso-footer-margin:57.95pt;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h15;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f15;
	mso-paper-source:0;}
div.WordSection15
	{page:WordSection15;}
@page WordSection16
	{size:8.5in 11.0in;
	margin:21.0pt 31.0pt 0in 32.0pt;
	mso-header-margin:0in;
	mso-footer-margin:0in;
	mso-header:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") h16;
	mso-footer:url("Moderna-v-Pfizer-DCT-Claim-Construction_files/header.htm") f16;
	mso-paper-source:0;}
div.WordSection16
	{page:WordSection16;}
 /* List Definitions */
 @list l0
	{mso-list-id:495998780;
	mso-list-type:hybrid;
	mso-list-template-ids:-1440054588 847676504 -1822106176 -793202638 110409500 1416377826 -1880217326 -30874544 -1852169224 988443366;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:93.95pt;
	text-indent:-18.05pt;
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:Symbol;
	mso-fareast-font-family:Symbol;
	mso-bidi-font-family:Symbol;
	mso-font-width:100%;
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:normal;
	mso-ansi-font-style:normal;
	mso-bidi-font-style:normal;}
@list l0:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:139.5pt;
	text-indent:-18.05pt;}
@list l0:level3
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:185.0pt;
	text-indent:-18.05pt;}
@list l0:level4
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:230.5pt;
	text-indent:-18.05pt;}
@list l0:level5
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:276.0pt;
	text-indent:-18.05pt;}
@list l0:level6
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:321.5pt;
	text-indent:-18.05pt;}
@list l0:level7
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:367.0pt;
	text-indent:-18.05pt;}
@list l0:level8
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:412.5pt;
	text-indent:-18.05pt;}
@list l0:level9
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:458.0pt;
	text-indent:-18.05pt;}
@list l1
	{mso-list-id:1732852244;
	mso-list-type:hybrid;
	mso-list-template-ids:-1128616254 -656898982 135934146 -781167906 -1948460158 -1854390822 861567084 564932758 1700448310 2072254290;}
@list l1:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.35pt;
	text-indent:-13.8pt;
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Georgia",serif;
	mso-fareast-font-family:Georgia;
	mso-bidi-font-family:Georgia;
	letter-spacing:-.05pt;
	mso-font-width:100%;
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:normal;
	mso-ansi-font-style:normal;
	mso-bidi-font-style:normal;}
@list l1:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:135.9pt;
	text-indent:-13.8pt;}
@list l1:level3
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:181.8pt;
	text-indent:-13.8pt;}
@list l1:level4
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:227.7pt;
	text-indent:-13.8pt;}
@list l1:level5
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.8in;
	text-indent:-13.8pt;}
@list l1:level6
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:319.5pt;
	text-indent:-13.8pt;}
@list l1:level7
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:365.4pt;
	text-indent:-13.8pt;}
@list l1:level8
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:411.3pt;
	text-indent:-13.8pt;}
@list l1:level9
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\2022;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:6.35in;
	text-indent:-13.8pt;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:none;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2060"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="2"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in;word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Times New Roman",serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Times New Roman",serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Times New Roman",serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText align=center style='margin-top:12.5pt;margin-right:147.65pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'>UNITED
STATES DISTRICT COURT<span style='letter-spacing:-3.25pt'> </span>DISTRICT<span
style='letter-spacing:-.15pt'> </span>OF<span style='letter-spacing:-.25pt'> </span>MASSACHUSETTS</p>

<p class=MsoBodyText align=center style='margin-top:3.2pt;margin-right:147.85pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center;
line-height:31.8pt;mso-line-height-rule:exactly'>CIVIL ACTION NO. 22-11378-RGS<span
style='letter-spacing:-3.25pt'> </span>MODERNATX,<span style='letter-spacing:
-.15pt'> </span>INC.,</p>

<p class=MsoBodyText align=center style='margin-top:0in;margin-right:147.75pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center;
line-height:12.65pt;mso-line-height-rule:exactly'>and<span style='letter-spacing:
-.15pt'> </span>MODERNA<span style='letter-spacing:-.05pt'> </span>US,<span
style='letter-spacing:-.1pt'> </span>INC.</p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText align=center style='margin-top:0in;margin-right:147.85pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'>v.</p>

<p class=MsoBodyText><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText align=center style='margin-top:0in;margin-right:147.9pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'>PFIZER
INC., BIONTECH SE,<span style='letter-spacing:.05pt'> </span>BIONTECH
MANUFACTURING GMBH,<span style='letter-spacing:-3.3pt'> </span>and<span
style='letter-spacing:-.1pt'> </span>BIONTECH<span style='letter-spacing:-.1pt'>
</span>US<span style='letter-spacing:-.1pt'> </span>INC.</p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText align=center style='margin-top:.05pt;margin-right:147.85pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'>MEMORANDUM
AND ORDER ON<span style='letter-spacing:-3.25pt'> </span>CLAIM<span
style='letter-spacing:-.05pt'> </span>CONSTRUCTION</p>

<p class=MsoBodyText><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText align=center style='margin-top:0in;margin-right:147.85pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'>August<span
style='letter-spacing:-.15pt'> </span>1, 2023</p>

<p class=MsoBodyText style='margin-top:.1pt'><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt'>STEARNS,<span style='letter-spacing:
-.1pt'> </span>D.J.</p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>Plaintiffs<span
style='letter-spacing:.05pt'> </span><span class=SpellE>ModernaTX</span>,<span
style='letter-spacing:.05pt'> </span>Inc.<span style='letter-spacing:.05pt'> </span>and<span
style='letter-spacing:.05pt'> </span>Moderna<span style='letter-spacing:.05pt'>
</span>US,<span style='letter-spacing:.05pt'> </span>Inc.<span
style='letter-spacing:.05pt'> </span>(collectively,<span style='letter-spacing:
.05pt'> </span>Moderna) accuse defendants Pfizer Inc. (Pfizer), BioNTech SE,
BioNTech<span style='letter-spacing:.05pt'> </span>Manufacturing GmbH, and
BioNTech US Inc. (collectively, BioNTech) of<span style='letter-spacing:.05pt'>
</span>infringing<span style='letter-spacing:.05pt'> </span>United<span
style='letter-spacing:.05pt'> </span>States<span style='letter-spacing:.05pt'> </span>Patent<span
style='letter-spacing:.05pt'> </span>Nos.<span style='letter-spacing:.05pt'> </span>10,898,574<span
style='letter-spacing:.05pt'> </span>(the<span style='letter-spacing:.05pt'> </span>574<span
style='letter-spacing:.05pt'> </span>patent),<span style='letter-spacing:.05pt'>
</span>10,702,600 (the 600 patent), and 10,933,127 (the 127 patent).<span
style='letter-spacing:.05pt'> </span>Before the<span style='letter-spacing:
.05pt'> </span>court<span style='letter-spacing:.05pt'> </span>are<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>parties<span
style='letter-spacing:.05pt'> </span>briefs<span style='letter-spacing:.05pt'> </span>on<span
style='letter-spacing:.05pt'> </span>claim<span style='letter-spacing:.05pt'> </span>construction.<span
style='letter-spacing:.05pt'> </span>The<span style='letter-spacing:.05pt'> </span>court<span
style='letter-spacing:.05pt'> </span>received<span style='letter-spacing:-3.25pt'>
</span>tutorial<span style='letter-spacing:.05pt'> </span>presentations<span
style='letter-spacing:.05pt'> </span>and<span style='letter-spacing:.05pt'> </span>heard<span
style='letter-spacing:.05pt'> </span>argument<span style='letter-spacing:.05pt'>
</span>pursuant<span style='letter-spacing:.05pt'> </span>to<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>Markman<span
style='letter-spacing:.05pt'> </span>v.<span style='letter-spacing:.05pt'> </span>Westview<span
style='letter-spacing:.65pt'> </span>Instruments,<span style='letter-spacing:
.75pt'> </span>Inc.</i>,<span style='letter-spacing:.75pt'> </span>517<span
style='letter-spacing:.75pt'> </span>U.S.<span style='letter-spacing:.75pt'> </span>370<span
style='letter-spacing:.7pt'> </span>(1996),<span style='letter-spacing:.9pt'> </span>on<span
style='letter-spacing:.7pt'> </span>July<span style='letter-spacing:.85pt'> </span>27,<span
style='letter-spacing:.9pt'> </span>2023.</p>

</div>

<span style='font-size:11.0pt;line-height:200%;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection2>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<h1 style='margin-top:12.9pt'>THE<span style='letter-spacing:-.1pt'> </span>PATENTS</h1>

<p class=MsoBodyText style='margin-top:.55pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.7pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>The<span style='letter-spacing:
-.45pt'> </span>574<span style='letter-spacing:-.45pt'> </span>patent,<span
style='letter-spacing:-.45pt'> </span>which<span style='letter-spacing:-.45pt'>
</span>issued<span style='letter-spacing:-.5pt'> </span>on<span
style='letter-spacing:-.45pt'> </span>January<span style='letter-spacing:-.4pt'>
</span>26,<span style='letter-spacing:-.45pt'> </span>2021,<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.5pt'> </span>claims<span
style='letter-spacing:-.4pt'> </span>priority<span style='letter-spacing:-3.25pt'>
</span>to<span style='letter-spacing:-.5pt'> </span>April<span
style='letter-spacing:-.45pt'> </span>2,<span style='letter-spacing:-.45pt'> </span>2012,<span
style='letter-spacing:-.45pt'> </span>is<span style='letter-spacing:-.6pt'> </span>entitled<span
style='letter-spacing:-.5pt'> </span>Delivery<span style='letter-spacing:-.45pt'>
</span>and<span style='letter-spacing:-.5pt'> </span>Formulation<span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.6pt'> </span>Engineered<span
style='letter-spacing:-.5pt'> </span>Nucleic<span style='letter-spacing:-3.25pt'>
</span>Acids.<span style='letter-spacing:.05pt'> </span>It is directed to the
delivery of modified mRNA molecules in order<span style='letter-spacing:.05pt'>
</span>to modulate protein expression.<span style='letter-spacing:.05pt'> </span>574
patent, col. 4, ll. 65-67; <i style='mso-bidi-font-style:normal'>see also id.</i>,<span
style='letter-spacing:.05pt'> </span>col. 1, ll. 32-34.<span style='letter-spacing:
.05pt'> </span>mRNA, or messenger ribonucleic acid, contains the genetic<span
style='letter-spacing:.05pt'> </span>information needed for ribosomes to create
a protein.<span style='letter-spacing:.05pt'> </span>For more than a<span
style='letter-spacing:.05pt'> </span>decade,<span style='letter-spacing:.05pt'>
</span>scientists<span style='letter-spacing:.05pt'> </span>have<span
style='letter-spacing:.05pt'> </span>recognized<span style='letter-spacing:
.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>potential<span
style='letter-spacing:.05pt'> </span>value<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>mRNA<span style='letter-spacing:.05pt'> </span>in<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>development
of more effective vaccines:<span style='letter-spacing:.05pt'> </span>If mRNA
containing the genetic<span style='letter-spacing:.05pt'> </span>information for
a viral protein could be introduced directly into the human<span
style='letter-spacing:.05pt'> </span>body, it could teach the body to create
antibodies to combat a virus without<span style='letter-spacing:.05pt'> </span>having
to introduce the virus itself.<span style='letter-spacing:.05pt'> </span>The
problem to be solved was this:<span style='letter-spacing:.05pt'> </span>The<span
style='letter-spacing:-3.25pt'> </span>introduction of foreign mRNA ordinarily
induces an innate immune system<span style='letter-spacing:-3.25pt'> </span>response,
causing the body to destroy the mRNA before it can be processed<span
style='letter-spacing:.05pt'> </span>by the bodys ribosomes.<span
style='letter-spacing:.05pt'> </span>The claimed invention proposes a solution
to that<span style='letter-spacing:.05pt'> </span>problem.<span
style='letter-spacing:.05pt'> </span>It describes vaccine compositions (and
methods of administering<span style='letter-spacing:.05pt'> </span>such<span
style='letter-spacing:1.95pt'> </span>compositions)<span style='letter-spacing:
1.95pt'> </span>in<span style='letter-spacing:2.0pt'> </span>which<span
style='letter-spacing:2.0pt'> </span>the<span style='letter-spacing:2.1pt'> </span>uridine<span
style='letter-spacing:2.1pt'> </span>nucleosides<a href="#_bookmark0"><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;
text-underline:none'>1</span></a><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:200%;position:relative;top:-3.5pt;mso-text-raise:3.5pt;
letter-spacing:1.05pt'><span style='mso-spacerun:yes'>&nbsp;</span></span>have<span
style='letter-spacing:2.1pt'> </span>been<span style='letter-spacing:2.0pt'> </span><span
class=GramE>replaced</span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.45pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape4" o:spid="_x0000_s2058" style='position:absolute;margin-left:1in;
  margin-top:9.05pt;width:2in;height:.7pt;z-index:-15728640;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape4"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:6.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.45pt;margin-right:40.75pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt'><a name="_bookmark0"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>1<span style='letter-spacing:.05pt'> </span></span>Nucleosides
are nucleobases attached to <span class=GramE>a</span> sugar.<span
style='letter-spacing:.05pt'> </span>The four mRNA<span style='letter-spacing:
.05pt'> </span>nucleobases are adenine, guanine, cytosine, and uracil.<span
style='letter-spacing:.05pt'> </span>The corresponding<span style='letter-spacing:
.05pt'> </span>nucleosides are adenine, guanine, cytosine, and uridine.<span
style='letter-spacing:.05pt'> </span>A ribosome will<span style='letter-spacing:
.05pt'> </span>translate<span style='letter-spacing:.05pt'> </span>different<span
style='letter-spacing:.05pt'> </span>sequences<span style='letter-spacing:.05pt'>
</span>of<span style='letter-spacing:.05pt'> </span>nucleosides<span
style='letter-spacing:.05pt'> </span>(and<span style='letter-spacing:.05pt'> </span>their<span
style='letter-spacing:.05pt'> </span>corresponding<span style='letter-spacing:
.05pt'> </span>nucleobases)<span style='letter-spacing:-.1pt'> </span>into<span
style='letter-spacing:-.05pt'> </span>different<span style='letter-spacing:
-.1pt'> </span>proteins.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection3>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:19.05pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-indent:-.05pt;line-height:
200%'>with<span style='letter-spacing:-.05pt'> </span>a<span style='letter-spacing:
.05pt'> </span>modified<span style='letter-spacing:-.05pt'> </span>form of<span
style='letter-spacing:-.05pt'> </span>uridine.<span style='letter-spacing:.15pt'>
</span>This<span style='letter-spacing:.2pt'> </span>substitution<span
style='letter-spacing:-.05pt'> </span>substantially<span style='letter-spacing:
.1pt'> </span>reduces<span style='letter-spacing:.1pt'> </span>the<span
style='letter-spacing:-3.25pt'> </span>bodys<span style='letter-spacing:-.05pt'>
</span>innate immune system<span style='letter-spacing:-.1pt'> </span>response<span
style='letter-spacing:-.1pt'> </span>to<span style='letter-spacing:-.05pt'> </span>the<span
style='letter-spacing:-.05pt'> </span>mRNA.</p>

<p class=MsoBodyText style='margin-left:76.0pt;line-height:15.9pt;mso-line-height-rule:
exactly'>Claims<span style='letter-spacing:-.05pt'> </span>1<span
style='letter-spacing:-.15pt'> </span>and<span style='letter-spacing:-.1pt'> </span>2<span
style='letter-spacing:-.1pt'> </span>of<span style='letter-spacing:-.1pt'> </span>the<span
style='letter-spacing:-.05pt'> </span>574<span style='letter-spacing:-.05pt'> </span>patent<span
style='letter-spacing:-.15pt'> </span><span class=GramE>are</span><span
style='letter-spacing:-.05pt'> </span>representative:</p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='margin-top:0in;margin-right:76.75pt;
margin-bottom:0in;margin-left:90.35pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:0in;mso-list:l1 level1 lfo2;
tab-stops:104.2pt'><![if !supportLists]><span style='font-size:14.0pt;
letter-spacing:-.05pt'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'>A method of producing a polypeptide of interest in a cell in<span
style='letter-spacing:.05pt'> </span>a subject in need thereof, comprising
administering to the<span style='letter-spacing:.05pt'> </span>subject a
pharmaceutical composition comprising a modified<span style='letter-spacing:
.05pt'> </span>messenger<span style='letter-spacing:.05pt'> </span>RNA<span
style='letter-spacing:.05pt'> </span>(<span class=SpellE>mmRNA</span>)<span
style='letter-spacing:.05pt'> </span>such<span style='letter-spacing:.05pt'> </span>that<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span><span
class=SpellE>mmRNA</span><span style='letter-spacing:.05pt'> </span>is<span
style='letter-spacing:.05pt'> </span>introduced into the cell, wherein the <span
class=SpellE>mmRNA</span> comprises a<span style='letter-spacing:.05pt'> </span>translatable
region encoding the polypeptide of interest and<span style='letter-spacing:
.05pt'> </span>comprises the modified nucleoside 1-methyl-pseudouridine,<span
style='letter-spacing:.05pt'> </span>and wherein the pharmaceutical composition
comprises an<span style='letter-spacing:.05pt'> </span>effective<span
style='letter-spacing:.05pt'> </span>amount<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span><span
class=SpellE>mmRNA</span><span style='letter-spacing:.05pt'> </span>providing<span
style='letter-spacing:.05pt'> </span>for<span style='letter-spacing:.05pt'> </span>increased<span
style='letter-spacing:.05pt'> </span>polypeptide<span style='letter-spacing:
.05pt'> </span>production<span style='letter-spacing:.05pt'> </span>and<span
style='letter-spacing:.05pt'> </span>substantially<span style='letter-spacing:
.05pt'> </span>reduced<span style='letter-spacing:.05pt'> </span>innate<span
style='letter-spacing:.05pt'> </span>immune response in the cell, as compared
to a composition<span style='letter-spacing:.05pt'> </span>comprising<span
style='letter-spacing:-.05pt'> </span>a<span style='letter-spacing:-.05pt'> </span>corresponding<span
style='letter-spacing:-.05pt'> </span>unmodified<span style='letter-spacing:
-.05pt'> </span>mRNA.<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='margin-left:105.35pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-15.05pt;mso-list:l1 level1 lfo2;
tab-stops:105.4pt'><![if !supportLists]><span style='font-size:14.0pt;
letter-spacing:-.05pt'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'>A<span style='letter-spacing:-.2pt'> </span>pharmaceutical<span
style='letter-spacing:-.15pt'> </span>composition<span style='letter-spacing:
-.2pt'> </span>comprising:<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:76.75pt;margin-bottom:
0in;margin-left:90.35pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph'>a plurality of lipid nanoparticles comprising a cationic
lipid, a<span style='letter-spacing:-3.25pt'> </span>sterol,<span
style='letter-spacing:-.05pt'> </span>and<span style='letter-spacing:-.05pt'> </span>a<span
style='letter-spacing:-.05pt'> </span>PEG-lipid,</p>

<p class=MsoBodyText style='margin-top:.05pt'><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:76.8pt;margin-bottom:
0in;margin-left:90.35pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph'>wherein the lipid nanoparticles comprise an mRNA encoding<span
style='letter-spacing:.05pt'> </span>a polypeptide, where in the mRNA comprises
one or more<span style='letter-spacing:.05pt'> </span>uridines, one or more
cytidines, one or more adenosines, and<span style='letter-spacing:.05pt'> </span>one<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.4pt'> </span>more<span
style='letter-spacing:-.4pt'> </span>guanosines<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>wherein<span
style='letter-spacing:-.4pt'> </span>substantially<span style='letter-spacing:
-.35pt'> </span>all<span style='letter-spacing:-.25pt'> </span>uridines<span
style='letter-spacing:-3.25pt'> </span>are<span style='letter-spacing:-.05pt'> </span>modified<span
style='letter-spacing:-.05pt'> </span>uridines.</p>

<p class=MsoBodyText style='margin-top:.05pt'><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The 600 patent, which
issued on July 7, 2020, and the 127 patent,<span style='letter-spacing:.05pt'>
</span>which issued on March 2, 2021, are identically entitled Betacoronavirus<span
style='letter-spacing:.05pt'> </span>mRNA Vaccine.<span style='letter-spacing:
.05pt'> </span>The patents list the same inventors, share a specification<span
style='letter-spacing:.05pt'> </span>and<span style='letter-spacing:.3pt'> </span>priority<span
style='letter-spacing:.4pt'> </span>date,<span style='letter-spacing:.4pt'> </span>and<span
style='letter-spacing:.35pt'> </span>set<span style='letter-spacing:.3pt'> </span>out<span
style='letter-spacing:.3pt'> </span>substantially<span style='letter-spacing:
.4pt'> </span>similar<span style='letter-spacing:.4pt'> </span>claims.<span
style='letter-spacing:.75pt'> </span>Accordingly,<span style='letter-spacing:
.4pt'> </span>the</p>

</div>

<span style='font-size:11.0pt;line-height:200%;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection4>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'><span class=GramE>court</span> will cite to
the 600 patent except in the rare instances in which the<span
style='letter-spacing:.05pt'> </span>patents<span style='letter-spacing:-.05pt'>
</span>differ<span style='letter-spacing:-.05pt'> </span>in<span
style='letter-spacing:-.05pt'> </span>some material respect.</p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.7pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The<span
style='letter-spacing:.05pt'> </span>patents<span style='letter-spacing:.05pt'>
</span>are<span style='letter-spacing:.05pt'> </span>directed<span
style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>mRNA<span
style='letter-spacing:.05pt'> </span>vaccines<span style='letter-spacing:.05pt'>
</span>specifically<span style='letter-spacing:.05pt'> </span>targeting<span
style='letter-spacing:.05pt'> </span><span class=SpellE>betacoronaviruses</span>.<a
href="#_bookmark1"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>2</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:.05pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span>Claim 1 of the 600 patent and
claim 1 of the 127 patent<span style='letter-spacing:-3.25pt'> </span><span
class=GramE>are</span><span style='letter-spacing:-.05pt'> </span>representative.<span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt'>3<span style='letter-spacing:.2pt'> </span></span>Claim<span
style='letter-spacing:-.05pt'> </span>1<span style='letter-spacing:-.1pt'> </span>of<span
style='letter-spacing:-.05pt'> </span>the 600 patent<span style='letter-spacing:
-.1pt'> </span>reads:</p>

<p class=MsoBodyText style='margin-top:0in;margin-right:76.75pt;margin-bottom:
0in;margin-left:90.35pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph'>1. A composition comprising: a messenger ribonucleic acid<span
style='letter-spacing:.05pt'> </span>(mRNA)<span style='letter-spacing:.05pt'> </span>comprising<span
style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'> </span>open<span
style='letter-spacing:.05pt'> </span>reading<span style='letter-spacing:.05pt'>
</span>frame<span style='letter-spacing:.05pt'> </span>encoding<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span><span
class=SpellE>betacoronavirus</span><span style='letter-spacing:.05pt'> </span>(<span
class=SpellE>BetaCoV</span>)<span style='letter-spacing:.05pt'> </span>S<span
style='letter-spacing:.05pt'> </span>protein<span style='letter-spacing:.05pt'>
</span>or<span style='letter-spacing:.05pt'> </span>S<span style='letter-spacing:
.05pt'> </span>protein<span style='letter-spacing:.05pt'> </span>subunit<span
style='letter-spacing:.05pt'> </span>formulated<span style='letter-spacing:
-.1pt'> </span>in<span style='letter-spacing:-.05pt'> </span>a<span
style='letter-spacing:-.05pt'> </span>lipid<span style='letter-spacing:-.05pt'>
</span>nanoparticle.</p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-left:39.95pt;text-align:justify;text-justify:
inter-ideograph'>And<span style='letter-spacing:-.1pt'> </span>claim<span
style='letter-spacing:-.1pt'> </span>1<span style='letter-spacing:-.1pt'> </span>of<span
style='letter-spacing:-.1pt'> </span>the 127<span style='letter-spacing:-.05pt'>
</span>patent<span style='letter-spacing:-.1pt'> </span>reads:</p>

<p class=MsoBodyText><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:76.7pt;margin-bottom:
0in;margin-left:90.35pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph'>1.<span style='letter-spacing:.05pt'> </span>A<span
style='letter-spacing:.05pt'> </span>method<span style='letter-spacing:.05pt'> </span>comprising<span
style='letter-spacing:.05pt'> </span>administering<span style='letter-spacing:
.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>a<span
style='letter-spacing:.05pt'> </span>subject<span style='letter-spacing:.05pt'>
</span>a<span style='letter-spacing:.05pt'> </span>messenger<span
style='letter-spacing:.05pt'> </span>ribonucleic<span style='letter-spacing:
.05pt'> </span>acid<span style='letter-spacing:.05pt'> </span>(mRNA)<span
style='letter-spacing:.05pt'> </span>comprising<span style='letter-spacing:
.05pt'> </span>an<span style='letter-spacing:.05pt'> </span>open<span
style='letter-spacing:.05pt'> </span>reading<span style='letter-spacing:.05pt'>
</span>frame<span style='letter-spacing:.05pt'> </span>encoding<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span><span
class=SpellE>betacoronavirus</span><span style='letter-spacing:.05pt'> </span>(<span
class=SpellE>BetaCoV</span>)<span style='letter-spacing:.05pt'> </span>S<span
style='letter-spacing:-3.25pt'> </span>protein<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.45pt'> </span>S<span style='letter-spacing:
-.25pt'> </span>protein<span style='letter-spacing:-.45pt'> </span>subunit<span
style='letter-spacing:-.4pt'> </span>formulated<span style='letter-spacing:
-.45pt'> </span>in<span style='letter-spacing:-.35pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>lipid<span style='letter-spacing:-.35pt'> </span>nanoparticle<span
style='letter-spacing:-3.25pt'> </span>in an effective amount to induce in the
subject an immune<span style='letter-spacing:.05pt'> </span>response<span
style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span><span class=SpellE>BetaCoV</span><span
style='letter-spacing:.05pt'> </span>S<span style='letter-spacing:.05pt'> </span>protein<span
style='letter-spacing:.05pt'> </span>or<span style='letter-spacing:.05pt'> </span>S<span
style='letter-spacing:.05pt'> </span>protein<span style='letter-spacing:.05pt'>
</span>subunit,<span style='letter-spacing:.05pt'> </span>wherein<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>lipid<span
style='letter-spacing:.05pt'> </span>nanoparticle<span style='letter-spacing:
.05pt'> </span>comprises<span style='letter-spacing:.05pt'> </span>20-60<span
style='letter-spacing:.05pt'> </span>mol<span style='letter-spacing:.05pt'> </span>%<span
style='letter-spacing:.05pt'> </span>ionizable cationic lipid, 5-25 mol %
neutral lipid, 25-55 mol %<span style='letter-spacing:-3.25pt'> </span>cholesterol,<span
style='letter-spacing:-.05pt'> </span>and<span style='letter-spacing:-.05pt'> </span>0.5-15<span
style='letter-spacing:-.05pt'> </span>mol<span style='letter-spacing:-.1pt'> </span>%<span
style='letter-spacing:-.05pt'> </span>PEG-modified<span style='letter-spacing:
-.05pt'> </span>lipid.</p>

<p class=MsoBodyText style='margin-top:.05pt'><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-left:75.95pt'>The<span style='letter-spacing:
-.1pt'> </span>parties<span style='letter-spacing:-.1pt'> </span>dispute<span
style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:-.1pt'> </span>following<span
style='letter-spacing:-.1pt'> </span>claim<span style='letter-spacing:-.25pt'> </span>terms:</p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='margin-left:93.95pt;mso-list:l0 level1 lfo1;
tab-stops:93.95pt 94.0pt'><![if !supportLists]><span style='font-size:14.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'>mRNA<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.05pt'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:93.95pt;margin-bottom:.0001pt;mso-list:l0 level1 lfo1;
tab-stops:93.95pt 94.0pt'><![if !supportLists]><span style='font-size:14.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'><span class=GramE>unmodified</span><span style='letter-spacing:-.15pt'>
</span>mRNA<o:p></o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.25pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape9" o:spid="_x0000_s2057" style='position:absolute;margin-left:1in;
  margin-top:11.15pt;width:2in;height:.7pt;z-index:-15728128;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape9"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:8.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.35pt;margin-right:40.7pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark1"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>2 </span>A <span class=SpellE>betacoronavirus</span>, as
will be later explained in more detail, is one of<span style='letter-spacing:
.05pt'> </span>four genera of enveloped, positive-strand RNA coronaviruses that
infect<span style='letter-spacing:.05pt'> </span>mammals.</p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:41.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;position:relative;top:-3.5pt;mso-text-raise:3.5pt'>3 </span>The 600
patent claims compositions, whereas the 127 patent claims<span
style='letter-spacing:-3.25pt'> </span>methods<span style='letter-spacing:-.05pt'>
</span>of<span style='letter-spacing:-.05pt'> </span>administering a<span
style='letter-spacing:-.05pt'> </span>composition.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection5>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='margin-top:12.85pt;text-indent:-18.1pt;
mso-list:l0 level1 lfo1;tab-stops:94.0pt 94.05pt'><![if !supportLists]><span
style='font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'><span class=SpellE>betacoronavirus</span><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.1pt'><span style='font-size:15.0pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='margin-top:.05pt;mso-list:l0 level1 lfo1;
tab-stops:94.0pt 94.05pt'><![if !supportLists]><span style='font-size:14.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'>S<span style='letter-spacing:-.1pt'> </span>protein<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph style='mso-list:l0 level1 lfo1;tab-stops:94.0pt 94.05pt'><![if !supportLists]><span
style='font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt'><span class=GramE>open</span><span style='letter-spacing:-.15pt'> </span>reading<span
style='letter-spacing:-.1pt'> </span>frame<o:p></o:p></span></p>

<p class=MsoBodyText><span style='font-size:17.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<h1 style='margin-top:12.5pt'>DISCUSSION</h1>

<p class=MsoBodyText><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.95pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>Claim construction is a
matter of law.<span style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:
normal'>See Markman</i>, 517 U.S. at<span style='letter-spacing:.05pt'> </span>388-389.<span
style='letter-spacing:.05pt'> </span>Claim terms are generally given [the]
ordinary and customary<span style='letter-spacing:.05pt'> </span>meaning that
would be ascribed by a person of ordinary skill in the art in<span
style='letter-spacing:.05pt'> </span>question at the time of the invention.<a
href="#_bookmark2"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>3</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:2.2pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span><i style='mso-bidi-font-style:
normal'>Phillips v. AWH Corp., </i>415 F.3d<span style='letter-spacing:.05pt'> </span>1303,<span
style='letter-spacing:.05pt'> </span>1312-1313<span style='letter-spacing:.05pt'>
</span>(Fed.<span style='letter-spacing:.05pt'> </span>Cir.<span
style='letter-spacing:.05pt'> </span>2005)<span style='letter-spacing:.05pt'> </span>(<span
class=SpellE>en</span><span style='letter-spacing:.05pt'> </span>banc),<span
style='letter-spacing:.05pt'> </span>quoting<span style='letter-spacing:.05pt'>
</span><span class=SpellE><i style='mso-bidi-font-style:normal'>Vitronics</i></span><i
style='mso-bidi-font-style:normal'><span style='letter-spacing:.05pt'> </span>Corp.<span
style='letter-spacing:.05pt'> </span>v.<span style='letter-spacing:.05pt'> </span><span
class=SpellE>Conceptronic</span>, Inc.</i>, 90 F.3d 1576, 1582 (Fed. Cir.
1996).<span style='mso-spacerun:yes'>&nbsp;&nbsp; </span>In determining<span
style='letter-spacing:.05pt'> </span>how a person of ordinary skill in the art
would have understood the claim<span style='letter-spacing:.05pt'> </span>terms<span
style='letter-spacing:.05pt'> </span>at the<span style='letter-spacing:.05pt'> </span>time<span
style='letter-spacing:.05pt'> </span>of the<span style='letter-spacing:.05pt'> </span>invention,<span
style='letter-spacing:3.35pt'> </span>the<span style='letter-spacing:3.4pt'> </span>court
looks<span style='letter-spacing:3.35pt'> </span>to the specification of<span
style='letter-spacing:-3.25pt'> </span>the<span style='letter-spacing:.05pt'> </span>patent,<span
style='letter-spacing:.05pt'> </span>its<span style='letter-spacing:.05pt'> </span>prosecution<span
style='letter-spacing:.05pt'> </span>history,<span style='letter-spacing:.05pt'>
</span>and,<span style='letter-spacing:.05pt'> </span>in<span style='letter-spacing:
.05pt'> </span>limited<span style='letter-spacing:.05pt'> </span>instances<span
style='letter-spacing:.05pt'> </span>where<span style='letter-spacing:.05pt'> </span>appropriate,<span
style='letter-spacing:.05pt'> </span>extrinsic<span style='letter-spacing:.05pt'>
</span>evidence<span style='letter-spacing:.05pt'> </span>such<span
style='letter-spacing:.05pt'> </span>as<span style='letter-spacing:.05pt'> </span>dictionaries,<span
style='letter-spacing:.05pt'> </span>treatises,<span style='letter-spacing:
.05pt'> </span>or<span style='letter-spacing:.05pt'> </span>expert<span
style='letter-spacing:-3.25pt'> </span>testimony.<span style='letter-spacing:
3.35pt'> </span><i style='mso-bidi-font-style:normal'>Id. </i>at 1315-1317.<span
style='letter-spacing:3.4pt'> </span>Ultimately, [t]he construction that stays
true<span style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:
.25pt'> </span>the<span style='letter-spacing:.15pt'> </span>claim<span
style='letter-spacing:.05pt'> </span>language<span style='letter-spacing:.15pt'>
</span>and<span style='letter-spacing:3.35pt'> </span>most<span
style='letter-spacing:3.3pt'> </span>naturally<span style='letter-spacing:.1pt'>
</span>aligns<span style='letter-spacing:.15pt'> </span>with<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.15pt'> </span><span
class=GramE>patents</span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.1pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape12" o:spid="_x0000_s2056" style='position:absolute;margin-left:1in;
  margin-top:11.55pt;width:2in;height:.7pt;z-index:-15727616;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape12"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:9.0pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.45pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:107%'><a name="_bookmark2"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:107%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt'>3<span style='letter-spacing:.05pt'> </span></span>The<span
style='letter-spacing:.05pt'> </span>parties<span style='letter-spacing:.05pt'>
</span>experts<span style='letter-spacing:.05pt'> </span>agree<span
style='letter-spacing:.05pt'> </span>that<span style='letter-spacing:.05pt'> </span>a<span
style='letter-spacing:.05pt'> </span>skilled<span style='letter-spacing:.05pt'>
</span>artisan<span style='letter-spacing:.05pt'> </span>would<span
style='letter-spacing:.05pt'> </span>have<span style='letter-spacing:.05pt'> </span>an<span
style='letter-spacing:.05pt'> </span>advanced degree and several years of
experience and be part of a larger<span style='letter-spacing:.05pt'> </span>research
team.<span style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:
normal'>See </i>Ho. Decl. [<span class=SpellE>Dkt</span> # 75]  14; Griffin
Decl. [<span class=SpellE>Dkt</span> # 76-4] <span style='letter-spacing:
.05pt'> </span>17-19.</p>

</div>

<span style='font-size:11.0pt;line-height:107%;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection6>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:12.9pt;margin-right:41.0pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt;line-height:200%'>description<span style='letter-spacing:1.55pt'> </span>of<span
style='letter-spacing:1.6pt'> </span>the<span style='letter-spacing:1.65pt'> </span>invention<span
style='letter-spacing:1.55pt'> </span>will<span style='letter-spacing:1.55pt'> </span>be,<span
style='letter-spacing:1.65pt'> </span>in<span style='letter-spacing:1.55pt'> </span>the<span
style='letter-spacing:1.65pt'> </span>end,<span style='letter-spacing:1.65pt'> </span>the<span
style='letter-spacing:1.65pt'> </span>correct<span style='letter-spacing:1.5pt'>
</span>construction.<span style='letter-spacing:-3.25pt'> </span><i
style='mso-bidi-font-style:normal'>Id.<span style='letter-spacing:.05pt'> </span></i>at
1316,<span style='letter-spacing:.05pt'> </span>quoting<span style='letter-spacing:
.05pt'> </span><i style='mso-bidi-font-style:normal'>Renishaw PLC v.<span
style='letter-spacing:3.35pt'> </span><span class=SpellE>Marposs</span> <span
class=SpellE>Societa</span> per <span class=SpellE>Azioni</span></i>,<span
style='letter-spacing:3.4pt'> </span>158<span style='letter-spacing:.05pt'> </span>F.3d<span
style='letter-spacing:.45pt'> </span>1243,<span style='letter-spacing:.4pt'> </span>1250<span
style='letter-spacing:.4pt'> </span>(Fed.<span style='letter-spacing:.4pt'> </span>Cir.<span
style='letter-spacing:.4pt'> </span>1998).<o:p></o:p></span></p>

<h2>mRNA</h2>

<p class=MsoBodyText style='margin-top:.55pt'><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>Moderna<span
style='letter-spacing:.05pt'> </span>initially<span style='letter-spacing:.05pt'>
</span>proposed<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>following<span style='letter-spacing:.05pt'>
</span>definition<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>mRNA:<span style='letter-spacing:-3.25pt'>
</span>messenger RNA, <i style='mso-bidi-font-style:normal'>i.e.</i>, a
ribonucleic acid (RNA) polynucleotide that encodes<span style='letter-spacing:
-3.25pt'> </span>a polypeptide of interest and can be translated to produce the
encoded<span style='letter-spacing:.05pt'> </span>polypeptide of interest.<span
style='letter-spacing:.05pt'> </span>Pfizer and BioNTech, for their part,
suggested that<span style='letter-spacing:-3.25pt'> </span>mRNA<span
style='letter-spacing:-.55pt'> </span>is<span style='letter-spacing:-.5pt'> </span>messenger<span
style='letter-spacing:-.6pt'> </span>ribonucleic<span style='letter-spacing:
-.65pt'> </span>acid,<span style='letter-spacing:-.5pt'> </span><i
style='mso-bidi-font-style:normal'>i.e.</i>,<span style='letter-spacing:-.5pt'>
</span>a<span style='letter-spacing:-.6pt'> </span>ribonucleic<span
style='letter-spacing:-.6pt'> </span>acid<span style='letter-spacing:-.6pt'> </span>(RNA)<span
style='letter-spacing:-.6pt'> </span>that<span style='letter-spacing:-.6pt'> </span>acts<span
style='letter-spacing:-3.25pt'> </span>as a template for protein synthesis
through the process of translation.<span style='letter-spacing:.05pt'> </span>In<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>wake<span
style='letter-spacing:.05pt'> </span>of the<span style='letter-spacing:.05pt'> </span>parties<span
style='letter-spacing:.05pt'> </span>responsive briefing<span style='letter-spacing:
.05pt'> </span>and concessions<span style='letter-spacing:.05pt'> </span>during<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span><i
style='mso-bidi-font-style:normal'>Markman<span style='letter-spacing:.05pt'> </span></i>hearing,<a
href="#_bookmark3"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>4</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:.05pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span>however,<span style='letter-spacing:
.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>only<span
style='letter-spacing:.05pt'> </span>dispute<span style='letter-spacing:.05pt'>
</span>that<span style='letter-spacing:.05pt'> </span>remains<span
style='letter-spacing:.05pt'> </span>is<span style='letter-spacing:.05pt'> </span>whether<span
style='letter-spacing:.05pt'> </span>mRNA acts as a template for encoding a
polypeptide or merely encodes<span style='letter-spacing:.05pt'> </span>and can
be translated to produce a polypeptide.<span style='letter-spacing:3.35pt'> </span><i
style='mso-bidi-font-style:normal'>See </i><span class=SpellE>Defs</span>.
Resp. Br. [<span class=SpellE>Dkt</span><span style='letter-spacing:.05pt'> </span>#<span
style='letter-spacing:-.15pt'> </span>96]<span style='letter-spacing:-.05pt'> </span>at<span
style='letter-spacing:-.1pt'> </span>6-7; Pls. Resp.<span style='letter-spacing:
-.1pt'> </span>Br.<span style='letter-spacing:-.1pt'> </span>[<span
class=SpellE>Dkt</span><span style='letter-spacing:-.1pt'> </span>#<span
style='letter-spacing:-.05pt'> </span>94]<span style='letter-spacing:-.05pt'> </span>at<span
style='letter-spacing:-.1pt'> </span>5-6.</p>

<p class=MsoBodyText style='margin-top:.1pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The court finds the
latter construction to be more consistent with the<span style='letter-spacing:
.05pt'> </span>intrinsic record.<span style='letter-spacing:.05pt'> </span>The
specification is rife with references to mRNA encoding<span style='letter-spacing:
-3.3pt'> </span>a<span style='letter-spacing:1.3pt'> </span>polypeptide<span
style='letter-spacing:1.3pt'> </span>and<span style='letter-spacing:1.2pt'> </span>being<span
style='letter-spacing:1.4pt'> </span>translated<span style='letter-spacing:
1.35pt'> </span>to<span style='letter-spacing:1.15pt'> </span>produce<span
style='letter-spacing:1.4pt'> </span>that<span style='letter-spacing:1.2pt'> </span>polypeptide.<span
style='letter-spacing:2.7pt'> </span><i style='mso-bidi-font-style:normal'>See,<span
style='letter-spacing:1.4pt'> </span>e.g.</i>,</p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.4pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape15" o:spid="_x0000_s2055" style='position:absolute;margin-left:1in;
  margin-top:13.6pt;width:2in;height:.7pt;z-index:-15727104;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image002.gif" v:shapes="docshape15"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:10.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.35pt;margin-right:0in;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-indent:35.95pt'><a
name="_bookmark3"></a><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
position:relative;top:-3.5pt;mso-text-raise:3.5pt'>4<span style='letter-spacing:
1.3pt'> </span></span>During<span style='letter-spacing:2.3pt'> </span>the<span
style='letter-spacing:2.2pt'> </span>oral<span style='letter-spacing:2.3pt'> </span>argument,<span
style='letter-spacing:2.2pt'> </span>Moderna<span style='letter-spacing:2.15pt'>
</span>agreed<span style='letter-spacing:2.2pt'> </span>to<span
style='letter-spacing:2.3pt'> </span>the<span style='letter-spacing:2.2pt'> </span>deletion<span
style='letter-spacing:2.2pt'> </span>of<span style='letter-spacing:2.25pt'> </span>the<span
style='letter-spacing:-3.25pt'> </span>modifier<span style='letter-spacing:
-.1pt'> </span>of<span style='letter-spacing:-.05pt'> </span>interest<span
style='letter-spacing:-.05pt'> </span>from<span style='letter-spacing:-.1pt'> </span>its
proposed<span style='letter-spacing:-.05pt'> </span>construction.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection7>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:-.05pt;line-height:200%'>574 patent, col. 5, ll.
11-12; <i style='mso-bidi-font-style:normal'>id.</i>, col. 5, ll. 41-42; <i
style='mso-bidi-font-style:normal'>id.</i>, col. 27, ll. 49-52; <i
style='mso-bidi-font-style:normal'>id.</i>, col.<span style='letter-spacing:
.05pt'> </span><span style='letter-spacing:-.05pt'>27,</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>ll.</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>65-67;</span><span
style='letter-spacing:-.65pt'> </span><i style='mso-bidi-font-style:normal'><span
style='letter-spacing:-.05pt'>id.</span></i><span style='letter-spacing:-.05pt'>,</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>col.</span><span
style='letter-spacing:-.75pt'> </span>28,<span style='letter-spacing:-.75pt'> </span>ll.<span
style='letter-spacing:-.7pt'> </span>7-8.<span style='letter-spacing:1.95pt'> </span>Defendants<span
style='letter-spacing:-.6pt'> </span>acts<span style='letter-spacing:-.6pt'> </span>as<span
style='letter-spacing:-.65pt'> </span>a<span style='letter-spacing:-.7pt'> </span>template<span
style='letter-spacing:-.65pt'> </span>for<span style='letter-spacing:-.8pt'> </span>encoding<span
style='letter-spacing:-3.25pt'> </span>language,<span style='letter-spacing:
-.05pt'> </span>in<span style='letter-spacing:-.05pt'> </span>contrast, is<span
style='letter-spacing:-.1pt'> </span>entirely missing from<span
style='letter-spacing:-.1pt'> </span>the text.<a href="#_bookmark4"><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;
text-underline:none'>5</span></a><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:200%'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>To the extent that Pfizer
and BioNTech seek to overcome this absence<span style='letter-spacing:-3.25pt'>
</span>by<span style='letter-spacing:.05pt'> </span>pointing<span
style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>testimony<span style='letter-spacing:.05pt'>
</span>of<span style='letter-spacing:.05pt'> </span>Modernas<span
style='letter-spacing:.05pt'> </span>expert,<span style='letter-spacing:.05pt'>
</span>Dr.<span style='letter-spacing:.05pt'> </span>David<span
style='letter-spacing:.05pt'> </span>Ho,<span style='letter-spacing:.05pt'> </span>or<span
style='letter-spacing:.05pt'> </span>contemporaneous dictionary definitions, <i
style='mso-bidi-font-style:normal'>see </i>Ho Dep. [<span class=SpellE>Dkt</span>
# 96-1] at 73:10-<span style='letter-spacing:-3.25pt'> </span>12; Ex. H to <span
class=SpellE>Defs</span>. Opening Br. [<span class=SpellE>Dkt</span> # 76-8]
at 5; Ex. I to <span class=SpellE>Defs</span>. Opening Br.<span
style='letter-spacing:.05pt'> </span>[<span class=SpellE>Dkt</span> # 76-9] at
4, their efforts are misdirected.<span style='letter-spacing:.05pt'> </span>Sources
extrinsic to the<span style='letter-spacing:.05pt'> </span>patent<span
style='letter-spacing:-.8pt'> </span>cannot<span style='letter-spacing:-.75pt'>
</span>be<span style='letter-spacing:-.65pt'> </span>used<span
style='letter-spacing:-.75pt'> </span>to<span style='letter-spacing:-.7pt'> </span>import<span
style='letter-spacing:-.75pt'> </span>limitations<span style='letter-spacing:
-.7pt'> </span>when<span style='letter-spacing:-.7pt'> </span>the<span
style='letter-spacing:-.75pt'> </span>appropriate<span style='letter-spacing:
-.7pt'> </span>definition<span style='letter-spacing:-3.25pt'> </span>can be
ascertained from the specification.<span style='letter-spacing:.05pt'> </span><i
style='mso-bidi-font-style:normal'>See Kaneka Corp. v. Xiamen<span
style='letter-spacing:.05pt'> </span><span class=SpellE>Kingdomway</span><span
style='letter-spacing:.05pt'> </span>Grp.<span style='letter-spacing:.05pt'> </span>Co.</i>,<span
style='letter-spacing:.05pt'> </span>790<span style='letter-spacing:.05pt'> </span>F.3d<span
style='letter-spacing:.05pt'> </span>1298,<span style='letter-spacing:.05pt'> </span>1305<span
style='letter-spacing:.05pt'> </span>(Fed.<span style='letter-spacing:.05pt'> </span>Cir.<span
style='letter-spacing:.05pt'> </span>2015);<span style='letter-spacing:.05pt'> </span><i
style='mso-bidi-font-style:normal'>see<span style='letter-spacing:.05pt'> </span>also<span
style='letter-spacing:-3.25pt'> </span><span class=SpellE>Sinorgchem</span><span
style='letter-spacing:-.25pt'> </span>Co.,<span style='letter-spacing:-.35pt'> </span>Shandong<span
style='letter-spacing:-.25pt'> </span>v.<span style='letter-spacing:-.35pt'> </span>Intl<span
style='letter-spacing:-.3pt'> </span>Trade<span style='letter-spacing:-.3pt'> </span>Commn</i>,<span
style='letter-spacing:-.3pt'> </span>511<span style='letter-spacing:-.3pt'> </span>F.3d<span
style='letter-spacing:-.3pt'> </span>1132,<span style='letter-spacing:-.2pt'> </span>1138<span
style='letter-spacing:-.25pt'> </span>(Fed.<span style='letter-spacing:-3.25pt'>
</span>Cir. 2007) (When the specification explains and defines a term used in
the<span style='letter-spacing:.05pt'> </span>claims, without ambiguity or
incompleteness, there is no need to search<span style='letter-spacing:.05pt'> </span>further<span
style='letter-spacing:-.5pt'> </span>for<span style='letter-spacing:-.45pt'> </span>the<span
style='letter-spacing:-.45pt'> </span>meaning<span style='letter-spacing:-.4pt'>
</span>of<span style='letter-spacing:-.5pt'> </span>the<span style='letter-spacing:
-.4pt'> </span>term.),<span style='letter-spacing:-.55pt'> </span>quoting<span
style='letter-spacing:-.4pt'> </span><i style='mso-bidi-font-style:normal'>Multiform<span
style='letter-spacing:-.5pt'> </span>Desiccants,<span style='letter-spacing:
-.4pt'> </span>Inc.<span style='letter-spacing:-.45pt'> </span>v.<span
style='letter-spacing:-3.25pt'> </span><span class=SpellE>Medzam</span>,<span
style='letter-spacing:.5pt'> </span>Ltd.</i>,<span style='letter-spacing:.55pt'>
</span>133<span style='letter-spacing:.55pt'> </span>F.3d<span
style='letter-spacing:.5pt'> </span>1473,<span style='letter-spacing:.55pt'> </span>1478<span
style='letter-spacing:.55pt'> </span>(Fed.<span style='letter-spacing:.55pt'> </span>Cir.<span
style='letter-spacing:.55pt'> </span>1998).<span style='letter-spacing:1.15pt'>
</span>The<span style='letter-spacing:.55pt'> </span>court<span
style='letter-spacing:.45pt'> </span>accordingly</p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.5pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape18" o:spid="_x0000_s2054" style='position:absolute;margin-left:1in;
  margin-top:13.65pt;width:2in;height:.7pt;z-index:-15726592;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape18"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:10.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.35pt;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark4"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>5<span style='letter-spacing:.05pt'> </span></span>Defendants<span
style='letter-spacing:.05pt'> </span>correctly<span style='letter-spacing:.05pt'>
</span>note<span style='letter-spacing:.05pt'> </span>that<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>574<span
style='letter-spacing:.05pt'> </span>patents<span style='letter-spacing:.05pt'>
</span>definition<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>expression mentions an RNA template.<span
style='letter-spacing:.05pt'> </span>The term, however, is only used<span
style='letter-spacing:-3.25pt'> </span>in<span style='letter-spacing:-.65pt'> </span>the<span
style='letter-spacing:-.5pt'> </span>context<span style='letter-spacing:-.6pt'>
</span>of<span style='letter-spacing:-.6pt'> </span><span class=SpellE>produc</span>[<span
class=SpellE>ing</span>]<span style='letter-spacing:-.55pt'> </span>an<span
style='letter-spacing:-.65pt'> </span>RNA<span style='letter-spacing:-.5pt'> </span>template<span
style='letter-spacing:-.5pt'> </span><i style='mso-bidi-font-style:normal'>from<span
style='letter-spacing:-.55pt'> </span>a<span style='letter-spacing:-.6pt'> </span>DNA<span
style='letter-spacing:-.5pt'> </span>sequence</i>.<span style='letter-spacing:
2.2pt'> </span>574<span style='letter-spacing:-3.25pt'> </span>patent, col.
48, ll. 66-67 (emphasis added).<span style='letter-spacing:.05pt'> </span>Other
language (<i style='mso-bidi-font-style:normal'>e.g.</i>, RNA<span
style='letter-spacing:.05pt'> </span>transcript or translation of an RNA) is
used to describe mRNA in the<span style='letter-spacing:.05pt'> </span>protein<span
style='letter-spacing:-.1pt'> </span>expression<span style='letter-spacing:
-.2pt'> </span>context.<span style='letter-spacing:3.35pt'> </span><i
style='mso-bidi-font-style:normal'>See<span style='letter-spacing:-.1pt'> </span>id.</i>,<span
style='letter-spacing:-.05pt'> </span>col. 48,<span style='letter-spacing:-.15pt'>
</span>l.<span style='letter-spacing:-.05pt'> </span>67; <i style='mso-bidi-font-style:
normal'>id.</i>,<span style='letter-spacing:-.05pt'> </span>col. 49,<span
style='letter-spacing:-.05pt'> </span>l.<span style='letter-spacing:-.05pt'> </span>2.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection8>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:0in;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;line-height:200%'>cannot<span
style='letter-spacing:.6pt'> </span>rely<span style='letter-spacing:.6pt'> </span>on<span
style='letter-spacing:.65pt'> </span>these<span style='letter-spacing:.75pt'> </span>sources<span
style='letter-spacing:.7pt'> </span>as<span style='letter-spacing:.7pt'> </span>a<span
style='letter-spacing:.6pt'> </span>persuasive<span style='letter-spacing:.6pt'>
</span>basis<span style='letter-spacing:.7pt'> </span>for<span
style='letter-spacing:.65pt'> </span>adopting<span style='letter-spacing:.75pt'>
</span>defendants<span style='letter-spacing:-3.25pt'> </span>construction.<a
href="#_bookmark5"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>6</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%'><o:p></o:p></span></p>

<h2><span class=GramE>unmodified</span><span style='letter-spacing:-.1pt'> </span>mRNA</h2>

<p class=MsoBodyText style='margin-top:.55pt'><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.7pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The parties agree that
the specification defines unmodified as any<span style='letter-spacing:.05pt'>
</span>substance, compound or molecule prior to being changed in any way.<span
style='letter-spacing:.05pt'> </span>574<span style='letter-spacing:.05pt'> </span>patent,<span
style='letter-spacing:.05pt'> </span>col.<span style='letter-spacing:.05pt'> </span>54,<span
style='letter-spacing:.05pt'> </span>ll.<span style='letter-spacing:.05pt'> </span>64-66.<span
style='letter-spacing:.05pt'> </span>Their<span style='letter-spacing:.05pt'> </span>disagreement<span
style='letter-spacing:.05pt'> </span>concerns<span style='letter-spacing:.05pt'>
</span>whether<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>definition also includes the later
sentence that [m]<span class=SpellE>olecules</span> may undergo a<span
style='letter-spacing:.05pt'> </span>series of modifications whereby each
modified molecule may serve as the<span style='letter-spacing:.05pt'> </span>unmodified
starting molecule for a subsequent modification.<span style='letter-spacing:
3.35pt'> </span><i style='mso-bidi-font-style:normal'>Id.</i>, col. 54,<span
style='letter-spacing:.05pt'> </span>l.<span style='letter-spacing:-.05pt'> </span>66-col.
55, l. 3.</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:40.7pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>The court agrees with Pfizer
and BioNTech that the disputed sentence<span style='letter-spacing:-3.25pt'> </span>provides<span
style='letter-spacing:.05pt'> </span>important<span style='letter-spacing:.05pt'>
</span>context<span style='letter-spacing:.05pt'> </span>for<span
style='letter-spacing:.05pt'> </span>understanding<span style='letter-spacing:
.05pt'> </span>what<span style='letter-spacing:.05pt'> </span>it<span
style='letter-spacing:.05pt'> </span>means<span style='letter-spacing:.05pt'> </span>to<span
style='letter-spacing:.05pt'> </span>be<span style='letter-spacing:-3.25pt'> </span>unmodified.<span
style='letter-spacing:.05pt'> </span>It broaden[s] . . . the definition set
forth in the first sentence,<span style='letter-spacing:-3.25pt'> </span>clarifying
that the crux of the matter is that the mRNA be unchanged in the<span
style='letter-spacing:.05pt'> </span>specific manner claimed by the patent, not
necessarily that it be unchanged<span style='letter-spacing:.05pt'> </span>in<span
style='letter-spacing:.35pt'> </span><i style='mso-bidi-font-style:normal'>all<span
style='letter-spacing:.4pt'> </span></i>respects.<a href="#_bookmark6"><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;
text-underline:none'>7</span></a><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:200%;position:relative;top:-3.5pt;mso-text-raise:3.5pt;
letter-spacing:1.2pt'><span style='mso-spacerun:yes'>&nbsp;</span></span><span
class=SpellE><i style='mso-bidi-font-style:normal'>Enanta</i></span><i
style='mso-bidi-font-style:normal'><span style='letter-spacing:.45pt'> </span>Pharms.,<span
style='letter-spacing:.45pt'> </span>Inc.<span style='letter-spacing:.35pt'> </span>v.<span
style='letter-spacing:.5pt'> </span>Pfizer,<span style='letter-spacing:.5pt'> </span>Inc.</i>,<span
style='letter-spacing:.3pt'> </span>2023<span style='letter-spacing:.35pt'> </span>WL<span
style='letter-spacing:.35pt'> </span>3269647,<span style='letter-spacing:.4pt'>
</span>at</p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.35pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:5.0pt;margin-right:40.65pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt'><a name="_bookmark5"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>6<span style='letter-spacing:.05pt'> </span></span>While<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>court<span
style='letter-spacing:.05pt'> </span>finds<span style='letter-spacing:.05pt'> </span>nothing<span
style='letter-spacing:.05pt'> </span>objectionable<span style='letter-spacing:
.05pt'> </span>about<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>term<span style='letter-spacing:.05pt'> </span>template,
the term adds nothing of value to an understanding of the claim<span
style='letter-spacing:-3.25pt'> </span>term.</p>

<p class=MsoBodyText style='margin-top:.05pt'><span style='font-size:9.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:5.05pt;margin-right:19.05pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-indent:.5in'><a
name="_bookmark6"></a><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:-.05pt'>7</span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt;letter-spacing:.45pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span><span style='letter-spacing:-.05pt'>For</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>example,</span><span
style='letter-spacing:-.7pt'> </span><span class=SpellE>pseudouridine</span>,<span
style='letter-spacing:-.75pt'> </span>which<span style='letter-spacing:-.75pt'>
</span>is<span style='letter-spacing:-.75pt'> </span>a<span style='letter-spacing:
-.75pt'> </span>modified<span style='letter-spacing:-.85pt'> </span>form<span
style='letter-spacing:-.75pt'> </span>of<span style='letter-spacing:-.8pt'> </span>uridine,<span
style='letter-spacing:-.75pt'> </span>may<span style='letter-spacing:-3.25pt'> </span>serve<span
style='letter-spacing:-.05pt'> </span>as<span style='letter-spacing:-.05pt'> </span>the<span
style='letter-spacing:-.05pt'> </span>unmodified<span style='letter-spacing:
-.1pt'> </span>comparator<span style='letter-spacing:-.1pt'> </span>for<span
style='letter-spacing:-.1pt'> </span>1-methyl-pseudouridine.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection9>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.7pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:-.05pt;line-height:200%'>*4<span style='letter-spacing:
-.55pt'> </span>(D.<span style='letter-spacing:-.55pt'> </span>Mass.<span
style='letter-spacing:-.55pt'> </span>May<span style='letter-spacing:-.45pt'> </span>5,<span
style='letter-spacing:-.6pt'> </span>2023).<span style='letter-spacing:2.45pt'>
</span>The<span style='letter-spacing:-.45pt'> </span>definition,<span
style='letter-spacing:-.45pt'> </span>however,<span style='letter-spacing:-.45pt'>
</span>is<span style='letter-spacing:-.5pt'> </span>incomplete<span
style='letter-spacing:-.55pt'> </span>and<span style='letter-spacing:-.5pt'> </span>could<span
style='letter-spacing:-3.25pt'> </span>confuse<span style='letter-spacing:.05pt'>
</span>the<span style='letter-spacing:.05pt'> </span>jury<span
style='letter-spacing:.05pt'> </span>without<span style='letter-spacing:.05pt'>
</span>the<span style='letter-spacing:.05pt'> </span>intervening<span
style='letter-spacing:.05pt'> </span>transitional<span style='letter-spacing:
.05pt'> </span>sentence<span style='letter-spacing:.05pt'> </span>that<span
style='letter-spacing:.05pt'> </span>[u]<span class=SpellE>nmodified</span><span
style='letter-spacing:-.65pt'> </span>may,<span style='letter-spacing:-.5pt'> </span>but<span
style='letter-spacing:-.5pt'> </span>does<span style='letter-spacing:-.45pt'> </span>not<span
style='letter-spacing:-.5pt'> </span>always,<span style='letter-spacing:-.45pt'>
</span>refer<span style='letter-spacing:-.45pt'> </span>to<span
style='letter-spacing:-.45pt'> </span>the<span style='letter-spacing:-.45pt'> </span>wild<span
style='letter-spacing:-.45pt'> </span>type<span style='letter-spacing:-.45pt'> </span>or<span
style='letter-spacing:-.45pt'> </span>native<span style='letter-spacing:-.55pt'>
</span>form<span style='letter-spacing:-3.25pt'> </span>of a biomolecule.<span
style='letter-spacing:.05pt'> </span>574 patent, col. 54, ll. 66-67; <i
style='mso-bidi-font-style:normal'>see <span class=SpellE>Stragent</span>, LLC
v. BMW<span style='letter-spacing:.05pt'> </span>of<span style='letter-spacing:
-.65pt'> </span>N.<span style='letter-spacing:-.5pt'> </span>Am.,<span
style='letter-spacing:-.5pt'> </span>LLC</i>,<span style='letter-spacing:-.45pt'>
</span>2022<span style='letter-spacing:-.6pt'> </span>WL<span style='letter-spacing:
-.55pt'> </span>3212081,<span style='letter-spacing:-.45pt'> </span>at<span
style='letter-spacing:-.6pt'> </span>*4<span style='letter-spacing:-.6pt'> </span>(D.<span
style='letter-spacing:-.6pt'> </span>Del.<span style='letter-spacing:-.65pt'> </span>Aug.<span
style='letter-spacing:-.5pt'> </span>9,<span style='letter-spacing:-.45pt'> </span>2022)<span
style='letter-spacing:-.6pt'> </span>([T]he<span style='letter-spacing:-.5pt'>
</span>Court</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'>will<span style='letter-spacing:-.75pt'> </span>not<span
style='letter-spacing:-.8pt'> </span>call-out<span style='letter-spacing:-.8pt'>
</span>one<span style='letter-spacing:-.85pt'> </span><span class=GramE>particular<span
style='letter-spacing:-.75pt'> </span>embodiment</span><span style='letter-spacing:
-.8pt'> </span>and<span style='letter-spacing:-.8pt'> </span>run<span
style='letter-spacing:-.75pt'> </span>the<span style='letter-spacing:-.7pt'> </span>risk<span
style='letter-spacing:-.75pt'> </span>that<span style='letter-spacing:-.8pt'> </span>the<span
style='letter-spacing:-.7pt'> </span>jury<span style='letter-spacing:-.75pt'> </span>will<span
style='letter-spacing:-3.25pt'> </span>view that particular embodiment as a
requirement.). The court accordingly<span style='letter-spacing:-3.25pt'> </span>adopts<span
style='letter-spacing:-.05pt'> </span>the<span style='letter-spacing:-.1pt'> </span>entire
paragraph<span style='letter-spacing:-.05pt'> </span>as definitional.<a
href="#_bookmark7"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>8</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%'><o:p></o:p></span></p>

<h2><span class=SpellE>betacoronavirus</span></h2>

<p class=MsoBodyText><b style='mso-bidi-font-weight:normal'><i
style='mso-bidi-font-style:normal'><o:p>&nbsp;</o:p></i></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The parties agree that a <span
class=SpellE>betacoronavirus</span> is an enveloped, positive-<span
style='letter-spacing:.05pt'> </span>sense,<span style='letter-spacing:-.55pt'>
</span>single<span style='letter-spacing:-.65pt'> </span>stranded<span
style='letter-spacing:-.6pt'> </span>RNA<span style='letter-spacing:-.5pt'> </span>virus<span
style='letter-spacing:-.55pt'> </span>of<span style='letter-spacing:-.6pt'> </span>zoonotic<span
style='letter-spacing:-.6pt'> </span>origin<span style='letter-spacing:-.6pt'> </span>that<span
style='letter-spacing:-.6pt'> </span>belongs<span style='letter-spacing:-.55pt'>
</span>to<span style='letter-spacing:-.6pt'> </span>one<span style='letter-spacing:
-.5pt'> </span>of<span style='letter-spacing:-.6pt'> </span>the<span
style='letter-spacing:-3.25pt'> </span>four lineages of the <span class=SpellE>betacoronavirus</span>
genus of the subfamily <span class=SpellE>Coronavirinae</span><span
style='letter-spacing:.05pt'> </span>(e.g., OC43, HKU1, MERS-<span
class=SpellE>CoV</span>, and SARS-<span class=SpellE>CoV</span>).<span
style='letter-spacing:.05pt'> </span>They dispute, however,<span
style='letter-spacing:.05pt'> </span>whether this term encompasses <span
class=SpellE>betacoronaviruses</span> that came into existence<span
style='letter-spacing:.05pt'> </span>after<span style='letter-spacing:-.1pt'> </span>the
patents filing date<span style='letter-spacing:-.05pt'> </span>(October<span
style='letter-spacing:-.05pt'> </span>21, 2016).</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:76.05pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph'>Whether the<span style='letter-spacing:.15pt'> </span>claim<span
style='letter-spacing:-.05pt'> </span>term<span style='letter-spacing:.1pt'> </span>contains<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.15pt'> </span>temporal<span
style='letter-spacing:.15pt'> </span>limitation<span style='letter-spacing:
.1pt'> </span><span class=GramE>hinges</span><span style='letter-spacing:.15pt'>
</span>on<span style='letter-spacing:.1pt'> </span>the</p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:40.05pt;margin-bottom:.0001pt'><i style='mso-bidi-font-style:
normal'>meaning<span style='letter-spacing:4.1pt'> </span></i>of<span
style='letter-spacing:4.1pt'> </span>the<span style='letter-spacing:4.2pt'> </span>term<span
style='letter-spacing:4.1pt'> </span>to<span style='letter-spacing:4.1pt'> </span>a<span
style='letter-spacing:4.15pt'> </span>person<span style='letter-spacing:4.15pt'>
</span>of<span style='letter-spacing:4.0pt'> </span>ordinary<span
style='letter-spacing:4.15pt'> </span>skill<span style='letter-spacing:4.2pt'> </span>at<span
style='letter-spacing:4.1pt'> </span>the<span style='letter-spacing:4.2pt'> </span>time<span
style='letter-spacing:4.25pt'> </span>of<span style='letter-spacing:4.1pt'> </span>the</p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.45pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape24" o:spid="_x0000_s2053" style='position:absolute;margin-left:1in;
  margin-top:18.15pt;width:2in;height:.7pt;z-index:-15726080;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape24"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:14.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.35pt;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark7"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>8 </span>During the <i style='mso-bidi-font-style:normal'>Markman
</i>hearing, Pfizer and BioNTech did not object to<span style='letter-spacing:
-3.25pt'> </span>the court adopting a construction that includes all three
sentences, and<span style='letter-spacing:.05pt'> </span>Moderna<span
style='letter-spacing:.05pt'> </span>indicated<span style='letter-spacing:.05pt'>
</span>it<span style='letter-spacing:.05pt'> </span>would<span
style='letter-spacing:.05pt'> </span>be<span style='letter-spacing:.05pt'> </span>preferable<span
style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>adopting<span
style='letter-spacing:.05pt'> </span>defendants<span style='letter-spacing:
.05pt'> </span>two-<span style='letter-spacing:-3.25pt'> </span>sentence
construction.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection10>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:12.9pt;margin-right:40.7pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:-.05pt;line-height:200%'><span style='font-size:
14.0pt;mso-bidi-font-size:11.0pt;line-height:200%'>invention.<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>Bd.
of Tr. of Leland Stanford Junior Univ. v. Roche Molecular<span
style='letter-spacing:.05pt'> </span>Sys., Inc.</i>, 528 F. Supp. 2d 967, 980
(N.D. Cal. 2007) (emphasis in original).<span style='letter-spacing:-3.25pt'> </span>The
court accordingly must determine whether a skilled artisan would have<span
style='letter-spacing:.05pt'> </span>understood <span class=SpellE>betacoronavirus</span>
to refer to the specific subset of viruses then<span style='letter-spacing:
.05pt'> </span>in existence or a larger category of viruses, the contents of
which [might]<span style='letter-spacing:.05pt'> </span>expand over time.<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>Id.</i>;
<i style='mso-bidi-font-style:normal'>see also <span class=SpellE>Innogenetics</span>,
N.V. v. Abbott <span class=SpellE>Labys</span></i>, 512<span style='letter-spacing:
.05pt'> </span><span style='letter-spacing:-.05pt'>F.3d</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>1363,</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>1371-1372</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>(Fed.</span><span
style='letter-spacing:-.6pt'> </span>Cir.<span style='letter-spacing:-.7pt'> </span>2008);<span
style='letter-spacing:-.7pt'> </span><span class=SpellE><i style='mso-bidi-font-style:
normal'>SuperGuide</i></span><i style='mso-bidi-font-style:normal'><span
style='letter-spacing:-.65pt'> </span>Corp.<span style='letter-spacing:-.7pt'> </span>v.<span
style='letter-spacing:-.6pt'> </span>DirecTV<span style='letter-spacing:-.65pt'>
</span>Enters.,<span style='letter-spacing:-3.25pt'> </span>Inc.</i>,<span
style='letter-spacing:-.5pt'> </span>358<span style='letter-spacing:-.45pt'> </span>F.3d<span
style='letter-spacing:-.6pt'> </span>870,<span style='letter-spacing:-.5pt'> </span>878-880<span
style='letter-spacing:-.45pt'> </span>(Fed.<span style='letter-spacing:-.35pt'>
</span>Cir.<span style='letter-spacing:-.65pt'> </span>2004);<span
style='letter-spacing:-.5pt'> </span><i style='mso-bidi-font-style:normal'>Schering<span
style='letter-spacing:-.6pt'> </span>Corp.<span style='letter-spacing:-.5pt'> </span>v.<span
style='letter-spacing:-.5pt'> </span>Amgen<span style='letter-spacing:-.55pt'> </span>Inc.</i>,<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:40.0pt;text-align:justify;text-justify:
inter-ideograph'>222<span style='letter-spacing:-.2pt'> </span>F.3d<span
style='letter-spacing:-.1pt'> </span>1347,<span style='letter-spacing:-.05pt'> </span>1353-1354<span
style='letter-spacing:-.1pt'> </span>(Fed.<span style='letter-spacing:-.05pt'> </span>Cir.<span
style='letter-spacing:-.05pt'> </span>2000).</p>

<p class=MsoBodyText><o:p>&nbsp;</o:p></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.65pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:36.05pt;line-height:200%'>The<span
style='letter-spacing:-.5pt'> </span>intrinsic<span style='letter-spacing:-.5pt'>
</span>record<span style='letter-spacing:-.65pt'> </span>favors<span
style='letter-spacing:-.45pt'> </span>a<span style='letter-spacing:-.6pt'> </span>more<span
style='letter-spacing:-.45pt'> </span>expansive<span style='letter-spacing:
-.55pt'> </span>view.<span style='letter-spacing:2.35pt'> </span>The<span
style='letter-spacing:-.45pt'> </span>claims<span style='letter-spacing:-.55pt'>
</span>lack<span style='letter-spacing:-.6pt'> </span>any<span
style='letter-spacing:-3.25pt'> </span>explicit incorporation of a temporal
limitation, and nothing in the relevant<span style='letter-spacing:.05pt'> </span>definitional
paragraph independently compels the conclusion that, as used<span
style='letter-spacing:.05pt'> </span>in the claims, the term is meant to
exclude <span class=SpellE>betacoronaviruses</span> discovered or<span
style='letter-spacing:.05pt'> </span>developing post-filing.<a
href="#_bookmark8"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>9</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:.05pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span>To the contrary, the definition is
written in the type<span style='letter-spacing:-3.25pt'> </span>of broad
language a skilled artisan would expect to denote an open-ended<span
style='letter-spacing:.05pt'> </span>category.<span style='letter-spacing:.05pt'>
</span>The court also finds it significant that<span style='letter-spacing:
.05pt'> </span>the usage of the term<span style='letter-spacing:.05pt'> </span><span
class=SpellE>betacoronavirus</span><span style='letter-spacing:1.25pt'> </span>throughout<span
style='letter-spacing:1.25pt'> </span>the<span style='letter-spacing:1.35pt'> </span>specification<span
style='letter-spacing:1.25pt'> </span>is<span style='letter-spacing:1.35pt'> </span>consistent<span
style='letter-spacing:1.25pt'> </span>with<span style='letter-spacing:1.25pt'> </span>the<span
style='letter-spacing:1.35pt'> </span><span class=GramE>term</span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.3pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:5.05pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark8"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>9 </span>Although defendants point to use of the word
are in the definition,<span style='letter-spacing:.05pt'> </span>they were
unable, when asked during the <i style='mso-bidi-font-style:normal'>Markman </i>hearing,
to identify a<span style='letter-spacing:.05pt'> </span>single<span
style='letter-spacing:-.7pt'> </span>case<span style='letter-spacing:-.65pt'> </span>standing<span
style='letter-spacing:-.7pt'> </span>for<span style='letter-spacing:-.55pt'> </span>the<span
style='letter-spacing:-.7pt'> </span>proposition<span style='letter-spacing:
-.7pt'> </span>that<span style='letter-spacing:-.65pt'> </span>use<span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.65pt'> </span>the<span
style='letter-spacing:-.65pt'> </span>word<span style='letter-spacing:-.75pt'> </span>are<span
style='letter-spacing:-.6pt'> </span>implies<span style='letter-spacing:-.55pt'>
</span>the<span style='letter-spacing:-3.25pt'> </span>existence<span
style='letter-spacing:-.05pt'> </span>of<span style='letter-spacing:-.05pt'> </span>a<span
style='letter-spacing:-.05pt'> </span>temporal<span style='letter-spacing:-.1pt'>
</span>limitation.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection11>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'>having a wide, unbounded scope.<a
href="#_bookmark9"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>10</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:.05pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span>For example, the specification
explicitly<span style='letter-spacing:-3.25pt'> </span>states<span
style='letter-spacing:.05pt'> </span>that<span style='letter-spacing:.05pt'> </span>[o]<span
class=SpellE>ther</span><span style='letter-spacing:.05pt'> </span><span
class=SpellE>betacoronaviruses</span><span style='letter-spacing:.05pt'> </span>are<span
style='letter-spacing:.05pt'> </span>encompassed<span style='letter-spacing:
.05pt'> </span>by<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>present<span style='letter-spacing:.05pt'>
</span>disclosures, 600 patent, col. 8, ll. 2-3, and that [t]he present
disclosure is<span style='letter-spacing:.05pt'> </span>not limited by a
particular strain, <i style='mso-bidi-font-style:normal'>id.</i>, col. 35, ll.
45-47; <i style='mso-bidi-font-style:normal'>see also id.</i>, col. 36,<span
style='letter-spacing:.05pt'> </span>ll.<span style='letter-spacing:-.05pt'> </span>29-31.</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:40.7pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>That the patent examiner
interpreted the claims as being directed to<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>only</span><span style='letter-spacing:-.85pt'> </span><span
style='letter-spacing:-.05pt'>those</span><span style='letter-spacing:-.75pt'> </span><span
class=SpellE><span style='letter-spacing:-.05pt'>betacoronaviruses</span></span><span
style='letter-spacing:-.65pt'> </span>that<span style='letter-spacing:-.75pt'> </span>were<span
style='letter-spacing:-.8pt'> </span>known<span style='letter-spacing:-.7pt'> </span>to<span
style='letter-spacing:-.85pt'> </span>exist<span style='letter-spacing:-.95pt'>
</span>as<span style='letter-spacing:-.8pt'> </span>of<span style='letter-spacing:
-.85pt'> </span>October<span style='letter-spacing:-.8pt'> </span>21,<span
style='letter-spacing:-.65pt'> </span>2016,<span style='letter-spacing:-3.25pt'>
</span>does not give the court any pause.<a href="#_bookmark10"><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;
text-underline:none'>11</span></a><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:200%;position:relative;top:-3.5pt;mso-text-raise:3.5pt;
letter-spacing:.05pt'><span style='mso-spacerun:yes'>&nbsp;</span></span>While,
in certain circumstances, an<span style='letter-spacing:.05pt'> </span>examiners
interpretation might shed light on how a skilled artisan would<span
style='letter-spacing:.05pt'> </span>have<span style='letter-spacing:.05pt'> </span>understood<span
style='letter-spacing:.05pt'> </span>a term<span style='letter-spacing:.05pt'> </span>at<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>time<span
style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'> </span>application<span
style='letter-spacing:.05pt'> </span>was<span style='letter-spacing:.05pt'> </span>filed,<span
style='letter-spacing:.05pt'> </span>it<span style='letter-spacing:.05pt'> </span>cannot<span
style='letter-spacing:.05pt'> </span>overcome<span style='letter-spacing:-.05pt'>
</span>the<span style='letter-spacing:-.05pt'> </span>clear<span
style='letter-spacing:-.2pt'> </span>import<span style='letter-spacing:-.15pt'>
</span>of<span style='letter-spacing:-.1pt'> </span>the specification<span
style='letter-spacing:-.05pt'> </span>and<span style='letter-spacing:-.1pt'> </span>the<span
style='letter-spacing:-.05pt'> </span>claim<span style='letter-spacing:-.1pt'> </span>language.</p>

<h2 style='text-align:justify;text-justify:inter-ideograph;line-height:15.8pt;
mso-line-height-rule:exactly'>S<span style='letter-spacing:-.1pt'> </span>protein</h2>

<p class=MsoBodyText style='margin-top:.55pt'><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.85pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>Moderna<span
style='letter-spacing:.05pt'> </span>proposes<span style='letter-spacing:.05pt'>
</span>defining<span style='letter-spacing:.05pt'> </span>S<span
style='letter-spacing:.05pt'> </span>protein<span style='letter-spacing:.05pt'>
</span>simply<span style='letter-spacing:.05pt'> </span>as<span
style='letter-spacing:.05pt'> </span>spike<span style='letter-spacing:.05pt'> </span>protein.<span
style='letter-spacing:-3.25pt'> </span><span style='letter-spacing:-.05pt'>Pfizer</span><span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.85pt'> </span><span style='letter-spacing:-.05pt'>BioNTech,</span><span
style='letter-spacing:-.85pt'> </span>although<span style='letter-spacing:-.85pt'>
</span>not<span style='letter-spacing:-.95pt'> </span>disagreeing<span
style='letter-spacing:-.8pt'> </span>that<span style='letter-spacing:-.95pt'> </span>S<span
style='letter-spacing:-.8pt'> </span>protein<span style='letter-spacing:-.9pt'>
</span>stands<span style='letter-spacing:-.8pt'> </span>for<span
style='letter-spacing:-.9pt'> </span><span class=GramE>spike</span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.25pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape30" o:spid="_x0000_s2052" style='position:absolute;margin-left:1in;
  margin-top:11.15pt;width:2in;height:.7pt;z-index:-15725568;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape30"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:8.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.35pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt'><a name="_bookmark9"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>10 </span>In contrast, in <i style='mso-bidi-font-style:
normal'>Schering</i>, although broader categorical language was<span
style='letter-spacing:.05pt'> </span>later inserted into the claims, the
specification itself disclosed only a single<span style='letter-spacing:.05pt'>
</span>type<span style='letter-spacing:-.05pt'> </span>of<span
style='letter-spacing:-.1pt'> </span>polypeptide<span style='letter-spacing:
-.15pt'> </span>and<span style='letter-spacing:-.05pt'> </span>did<span
style='letter-spacing:-.1pt'> </span>not<span style='letter-spacing:-.15pt'> </span>contemplate<span
style='letter-spacing:-.05pt'> </span>the possibility<span style='letter-spacing:
-.15pt'> </span>of<span style='letter-spacing:-.1pt'> </span>other<span
style='letter-spacing:-.05pt'> </span>types.</p>

<p class=MsoBodyText style='margin-top:.55pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark10"></a><span
style='font-size:9.0pt;mso-bidi-font-size:11.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>11<span style='letter-spacing:.05pt'> </span></span><span
style='font-size:14.0pt;mso-bidi-font-size:11.0pt'>Because<span
style='letter-spacing:.05pt'> </span>Moderna<span style='letter-spacing:.05pt'>
</span>contemporaneously<span style='letter-spacing:.05pt'> </span>disputed<span
style='letter-spacing:.05pt'> </span>that<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>claims<span style='letter-spacing:.05pt'> </span>included
any such limitation, a finding of disclaimer is inappropriate.<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>See<span
style='letter-spacing:.05pt'> </span>Biogen Idec, Inc. v. GlaxoSmithKline LLC</i>,
713 F.3d 1090, 1096 (Fed. Cir.<span style='letter-spacing:.05pt'> </span>2013).<o:p></o:p></span></p>

</div>

<span style='font-size:14.0pt;mso-bidi-font-size:11.0pt;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection12>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'>protein,<a href="#_bookmark11"><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;
position:relative;top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;
text-underline:none'>12</span></a><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:200%;position:relative;top:-3.5pt;mso-text-raise:3.5pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span>seek to further define the term as
a structural protein encoded by<span style='letter-spacing:-3.25pt'> </span>a <span
class=SpellE>betacoronavirus</span> genome that mediates virus binding to cells
and virus<span style='letter-spacing:.05pt'> </span>entry<span
style='letter-spacing:-.05pt'> </span>via<span style='letter-spacing:-.05pt'> </span>fusion<span
style='letter-spacing:-.05pt'> </span>of<span style='letter-spacing:-.1pt'> </span>the
virus and<span style='letter-spacing:-.05pt'> </span>target<span
style='letter-spacing:-.25pt'> </span>cell membranes.</p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.7pt;margin-bottom:
0in;margin-left:39.9pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:36.05pt;line-height:200%'>The<span
style='letter-spacing:.05pt'> </span>court<span style='letter-spacing:.05pt'> </span>will<span
style='letter-spacing:.05pt'> </span>adopt<span style='letter-spacing:.05pt'> </span>Modernas<span
style='letter-spacing:.05pt'> </span>construction<span style='letter-spacing:
.05pt'> </span>(with<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>further<span style='letter-spacing:.05pt'>
</span>elaboration that spike protein is a structural protein forming a
spike to<span style='letter-spacing:.05pt'> </span>address defendants
concerns of possible jury confusion).<span style='letter-spacing:.05pt'> </span>The
only support<span style='letter-spacing:.05pt'> </span>Pfizer<span
style='letter-spacing:.05pt'> </span>and<span style='letter-spacing:.05pt'> </span>BioNTech<span
style='letter-spacing:.05pt'> </span>cite<span style='letter-spacing:.05pt'> </span>for<span
style='letter-spacing:.05pt'> </span>their<span style='letter-spacing:.05pt'> </span>proposed<span
style='letter-spacing:.05pt'> </span>virus<span style='letter-spacing:.05pt'> </span>binding<span
style='letter-spacing:.05pt'> </span>and<span style='letter-spacing:.05pt'> </span>entry<span
style='letter-spacing:.05pt'> </span>functionality description is a passage
explaining how MERS-<span class=SpellE>CoV</span> replicates<span
style='letter-spacing:.05pt'> </span>in the body during infections.<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>See </i>600
patent, col. 34, ll. 53-59.<span style='letter-spacing:.05pt'> </span>The means<span
style='letter-spacing:-3.3pt'> </span>by<span style='letter-spacing:.05pt'> </span>which<span
style='letter-spacing:.05pt'> </span>S<span style='letter-spacing:.05pt'> </span>protein<span
style='letter-spacing:.05pt'> </span>facilitates<span style='letter-spacing:
.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>infection<span
style='letter-spacing:.05pt'> </span>of<span style='letter-spacing:.05pt'> </span>humans<span
style='letter-spacing:.05pt'> </span>with<span style='letter-spacing:.05pt'> </span>a<span
style='letter-spacing:.05pt'> </span>live<span style='letter-spacing:.05pt'> </span><span
class=SpellE>betacoronavirus</span>,<span style='letter-spacing:.05pt'> </span>however<span
style='letter-spacing:.05pt'> </span>accurately<span style='letter-spacing:
.05pt'> </span>described<span style='letter-spacing:.05pt'> </span>by<span
style='letter-spacing:.05pt'> </span>Pfizer<span style='letter-spacing:.05pt'> </span>and<span
style='letter-spacing:.05pt'> </span>BioNTech,<span style='letter-spacing:-3.25pt'>
</span>holds limited relevance to how S protein operates in the context of the<span
style='letter-spacing:.05pt'> </span>claimed<span style='letter-spacing:-.7pt'>
</span>invention.<a href="#_bookmark12"><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:200%;color:windowtext;position:relative;
top:-3.5pt;mso-text-raise:3.5pt;text-decoration:none;text-underline:none'>13</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%;position:
relative;top:-3.5pt;mso-text-raise:3.5pt;letter-spacing:1.25pt'><span
style='mso-spacerun:yes'>&nbsp;</span></span><i style='mso-bidi-font-style:
normal'>See<span style='letter-spacing:-.65pt'> </span>Sequoia<span
style='letter-spacing:-.65pt'> </span>Tech.,<span style='letter-spacing:-.6pt'>
</span>LLC<span style='letter-spacing:-.65pt'> </span>v.<span style='letter-spacing:
-.6pt'> </span>Dell,<span style='letter-spacing:-.6pt'> </span>Inc.</i>,<span
style='letter-spacing:-.6pt'> </span>66<span style='letter-spacing:-.8pt'> </span>F.4th<span
style='letter-spacing:-.65pt'> </span>1317,<span style='letter-spacing:-.6pt'> </span>1326<span
style='letter-spacing:-3.3pt'> </span>(Fed. Cir. 2023) ([A] patents express
purpose of the invention informs the<span style='letter-spacing:-3.25pt'> </span>proper
construction of claim terms.), quoting <i style='mso-bidi-font-style:normal'>Kaken
Pharm. Co. v. Iancu</i>,<span style='letter-spacing:.05pt'> </span>952<span
style='letter-spacing:1.65pt'> </span>F.3d<span style='letter-spacing:1.7pt'> </span>1346,<span
style='letter-spacing:1.8pt'> </span>1352<span style='letter-spacing:1.7pt'> </span>(Fed.<span
style='letter-spacing:1.75pt'> </span>Cir.<span style='letter-spacing:1.8pt'> </span>2020);<span
style='letter-spacing:1.65pt'> </span><i style='mso-bidi-font-style:normal'>see<span
style='letter-spacing:1.7pt'> </span>also<span style='letter-spacing:1.9pt'> </span>Toro<span
style='letter-spacing:1.7pt'> </span>Co.<span style='letter-spacing:1.65pt'> </span>v.<span
style='letter-spacing:1.8pt'> </span>White<span style='letter-spacing:1.7pt'> </span>Consol.<o:p></o:p></i></p>

<p class=MsoBodyText><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoBodyText style='margin-top:.45pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape33" o:spid="_x0000_s2051" style='position:absolute;margin-left:1in;
  margin-top:9.05pt;width:2in;height:.7pt;z-index:-15725056;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape33"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<i style='mso-bidi-font-style:normal'><span style='font-size:6.5pt;mso-bidi-font-size:
14.0pt'><o:p></o:p></span></i></p>

<p class=MsoBodyText style='margin-top:6.45pt;margin-right:19.05pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-indent:.5in'><a
name="_bookmark11"></a><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
position:relative;top:-3.5pt;mso-text-raise:3.5pt'>12<span style='letter-spacing:
1.7pt'> </span></span>Nor<span style='letter-spacing:.55pt'> </span>could<span
style='letter-spacing:.5pt'> </span>they.<span style='letter-spacing:1.2pt'> </span>The<span
style='letter-spacing:.55pt'> </span>specification<span style='letter-spacing:
.55pt'> </span>repeatedly<span style='letter-spacing:.55pt'> </span>equates<span
style='letter-spacing:.55pt'> </span>S<span style='letter-spacing:.6pt'> </span>protein<span
style='letter-spacing:.5pt'> </span>and<span style='letter-spacing:-3.25pt'> </span>spike<span
style='letter-spacing:-.05pt'> </span>protein.<span style='letter-spacing:3.35pt'>
</span><i style='mso-bidi-font-style:normal'>See,<span style='letter-spacing:
-.15pt'> </span>e.g.</i>, 600<span style='letter-spacing:-.05pt'> </span>Patent,
col.<span style='letter-spacing:-.05pt'> </span>7, l.<span style='letter-spacing:
-.05pt'> </span>26; <i style='mso-bidi-font-style:normal'>id.</i>,<span
style='letter-spacing:-.05pt'> </span>col.<span style='letter-spacing:-.1pt'> </span>8,<span
style='letter-spacing:-.15pt'> </span>l. 41.</p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.8pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark12"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>13<span style='letter-spacing:.05pt'> </span></span>Its
functionality in the viral context may explain why researchers<span
style='letter-spacing:.05pt'> </span>chose to focus on S protein rather than
another <span class=SpellE>betacoronavirus</span> structural<span
style='letter-spacing:.05pt'> </span>protein. However, as used in the claimed
invention, S protein serves only an<span style='letter-spacing:-3.25pt'> </span>antigenic<span
style='letter-spacing:-.15pt'> </span>purpose;<span style='letter-spacing:-.05pt'>
</span>it<span style='letter-spacing:-.2pt'> </span>indisputably<span
style='letter-spacing:-.05pt'> </span>does<span style='letter-spacing:-.15pt'> </span>not<span
style='letter-spacing:-.2pt'> </span>mediate<span style='letter-spacing:-.05pt'>
</span>virus<span style='letter-spacing:-.2pt'> </span>binding<span
style='letter-spacing:-.05pt'> </span>or<span style='letter-spacing:-.15pt'> </span>entry.</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection13>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'><i style='mso-bidi-font-style:normal'>Indus.,<span
style='letter-spacing:.05pt'> </span>Inc.,<span style='letter-spacing:.05pt'> </span></i>266<span
style='letter-spacing:.05pt'> </span>F.3d<span style='letter-spacing:.05pt'> </span>1367,<span
style='letter-spacing:.05pt'> </span>1371-1372<span style='letter-spacing:.05pt'>
</span>(Fed.<span style='letter-spacing:.05pt'> </span>Cir.<span
style='letter-spacing:.05pt'> </span>2001)<span style='letter-spacing:.05pt'> </span>(construing<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>structural
term in accordance with its use in the claims, not its functionality<span
style='letter-spacing:-3.25pt'> </span>in<span style='letter-spacing:-.1pt'> </span>other<span
style='letter-spacing:-.05pt'> </span>contexts).</p>

<h2 style='margin-left:40.0pt;text-align:justify;text-justify:inter-ideograph'><span
class=GramE>open</span><span style='letter-spacing:-.1pt'> </span>reading<span
style='letter-spacing:-.15pt'> </span>frame</h2>

<p class=MsoBodyText style='margin-top:.55pt'><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='font-size:13.5pt;
mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.65pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>Moderna contends that
open reading frame means in a DNA, a<span style='letter-spacing:.05pt'> </span>continuous
stretch of DNA beginning with a start <span class=GramE>codon, and</span>
ending with a<span style='letter-spacing:.05pt'> </span>stop codon and encodes
a polypeptide, or, in an mRNA, a corresponding<span style='letter-spacing:.05pt'>
</span>stretch of mRNA.<span style='letter-spacing:.05pt'> </span>Pfizer and
BioNTech, on the other hand, argue that the<span style='letter-spacing:.05pt'> </span>term
<i style='mso-bidi-font-style:normal'>only </i>refers to a continuous stretch
of DNA beginning with a start<span style='letter-spacing:.05pt'> </span>codon
(e.g., methionine (ATG)), and ending with a stop codon (e.g., TAA,<span
style='letter-spacing:.05pt'> </span>TAG<span style='letter-spacing:-.15pt'> </span>or<span
style='letter-spacing:-.2pt'> </span>TGA)<span style='letter-spacing:-.15pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>encodes<span style='letter-spacing:-.15pt'>
</span>a<span style='letter-spacing:-.15pt'> </span>polypeptide,<span
style='letter-spacing:-.2pt'> </span>regardless<span style='letter-spacing:
-.1pt'> </span>of<span style='letter-spacing:-.1pt'> </span>the<span
style='letter-spacing:-.1pt'> </span>context<span style='letter-spacing:-.15pt'>
</span>in<span style='letter-spacing:-.1pt'> </span>which<span
style='letter-spacing:-3.25pt'> </span>it<span style='letter-spacing:-.1pt'> </span>is
used.</p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.7pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in;line-height:200%'>The<span style='letter-spacing:
.05pt'> </span>patent<span style='letter-spacing:.05pt'> </span>explicitly<span
style='letter-spacing:.05pt'> </span>states<span style='letter-spacing:.05pt'> </span>that<span
style='letter-spacing:.05pt'> </span>[a]n<span style='letter-spacing:.05pt'> </span>open<span
style='letter-spacing:.05pt'> </span>reading<span style='letter-spacing:.05pt'>
</span>frame<span style='letter-spacing:.05pt'> </span>is<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>continuous
stretch of DNA beginning with a start codon (e.g., methionine<span
style='letter-spacing:.05pt'> </span>(ATG)), and ending with a stop codon
(e.g., TAA, TAG or TGA) and encodes<span style='letter-spacing:-3.25pt'> </span>a
polypeptide. 600 patent, col. 62, ll. 50-53. The use of quotation marks in<span
style='letter-spacing:-3.25pt'> </span>combination with the word is typically
signifies an intent by the patentee<span style='letter-spacing:.05pt'> </span>to
define a term, ending further inquiry.<span style='letter-spacing:.05pt'> </span><i
style='mso-bidi-font-style:normal'>See <span class=SpellE>Sinorgchem</span></i>,
511 F.3d at 1138.<span style='letter-spacing:.05pt'> </span>Things<span
style='letter-spacing:.05pt'> </span>become<span style='letter-spacing:.05pt'> </span>more<span
style='letter-spacing:.05pt'> </span>complicated,<span style='letter-spacing:
.05pt'> </span>however,<span style='letter-spacing:.05pt'> </span>when,<span
style='letter-spacing:.05pt'> </span>as<span style='letter-spacing:.05pt'> </span>here,<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>alleged<span
style='letter-spacing:.05pt'> </span>definition<span style='letter-spacing:
.9pt'> </span>would<span style='letter-spacing:.9pt'> </span>operate<span
style='letter-spacing:1.05pt'> </span>to<span style='letter-spacing:.9pt'> </span>exclude<span
style='letter-spacing:1.05pt'> </span>nearly<span style='letter-spacing:1.0pt'>
</span>every<span style='letter-spacing:1.05pt'> </span>embodiment<span
style='letter-spacing:.9pt'> </span>described<span style='letter-spacing:.95pt'>
</span>in</p>

</div>

<span style='font-size:11.0pt;line-height:200%;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection14>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:12.9pt;margin-right:40.9pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'><span style='font-size:14.0pt;mso-bidi-font-size:
11.0pt;line-height:200%'>the patent and <span class=GramE>render[</span>]
asserted claims facially nonsensical.<span style='letter-spacing:.05pt'> </span><i
style='mso-bidi-font-style:normal'>Neville v.<span style='letter-spacing:.05pt'>
</span>Found. Constructors, Inc.</i>, 972 F.3d 1350, 1357 (Fed. Cir. 2020),
quoting<span style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:
normal'>Becton, Dickinson &amp; Co. v. Tyco Healthcare Grp., LP</i>, 616 F.3d
1249, 1255<span style='letter-spacing:.05pt'> </span>(Fed.<span
style='letter-spacing:.05pt'> </span>Cir.<span style='letter-spacing:.05pt'> </span>2010).<span
style='letter-spacing:.05pt'> </span>A<span style='letter-spacing:.05pt'> </span>claim<span
style='letter-spacing:.05pt'> </span>construction<span style='letter-spacing:
.05pt'> </span>that<span style='letter-spacing:.05pt'> </span>excludes<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>preferred<span
style='letter-spacing:-3.25pt'> </span>embodiment is rarely, if ever,
correct, and one that excludes <i style='mso-bidi-font-style:normal'>most </i>of
the<span style='letter-spacing:.05pt'> </span>preferred embodiments and
inherently conflicts with the plain text of the<span style='letter-spacing:
.05pt'> </span>claims is especially disfavored.<span style='letter-spacing:
.05pt'> </span><i style='mso-bidi-font-style:normal'>Kaneka Corp.</i>, 790 F.3d
at 1304, quoting<span style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:
normal'>MBO <span class=SpellE>Labys</span>, Inc. v. Becton, Dickinson &amp;
Co.</i>,<span style='letter-spacing:3.35pt'> </span>474 F.3d 1323, 1333<span
style='letter-spacing:3.4pt'> </span>(Fed.<span style='letter-spacing:.05pt'> </span>Cir.<span
style='letter-spacing:.55pt'> </span>2007);<span style='letter-spacing:.6pt'> </span><i
style='mso-bidi-font-style:normal'>see<span style='letter-spacing:.5pt'> </span>also<span
style='letter-spacing:.45pt'> </span>Neville</i>,<span style='letter-spacing:
.4pt'> </span>972<span style='letter-spacing:.5pt'> </span>F.3d<span
style='letter-spacing:.4pt'> </span>at<span style='letter-spacing:.5pt'> </span>1357.<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:40.75pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>Review<span
style='letter-spacing:2.7pt'> </span>of<span style='letter-spacing:2.75pt'> </span>the<span
style='letter-spacing:2.8pt'> </span>intrinsic<span style='letter-spacing:2.75pt'>
</span>record<span style='letter-spacing:2.75pt'> </span>further<span
style='letter-spacing:2.75pt'> </span>compels<span style='letter-spacing:2.8pt'>
</span>the<span style='letter-spacing:2.85pt'> </span>conclusion<span
style='letter-spacing:2.75pt'> </span>that<span style='letter-spacing:-3.25pt'>
</span>the patentee did not intend to act as lexicographer in this instance.<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>See<span
style='letter-spacing:.05pt'> </span>Baxalta Inc. v. Genentech, Inc.</i>, 972
F.3d 1341, 1347 (Fed. Cir. 2020).<span style='letter-spacing:.05pt'> </span>The<span
style='letter-spacing:.05pt'> </span>purported<span style='letter-spacing:.05pt'>
</span>definition<span style='letter-spacing:.05pt'> </span>is<span
style='letter-spacing:.05pt'> </span>one<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>series<span
style='letter-spacing:.05pt'> </span>of<span style='letter-spacing:.05pt'> </span>four<span
style='letter-spacing:.05pt'> </span>similar<span style='letter-spacing:.05pt'>
</span>paragraphs<span style='letter-spacing:.05pt'> </span>immediately<span
style='letter-spacing:.05pt'> </span>following<span style='letter-spacing:.05pt'>
</span>the<span style='letter-spacing:.05pt'> </span>description<span
style='letter-spacing:.05pt'> </span>of<span style='letter-spacing:.05pt'> </span>an<span
style='letter-spacing:.05pt'> </span>in<span style='letter-spacing:.05pt'> </span>vitro<span
style='letter-spacing:.05pt'> </span>transcription<span style='letter-spacing:
.05pt'> </span>template. 600 patent, col. 62, ll. 34-35; <i style='mso-bidi-font-style:
normal'>see also id.</i>, col. 62, ll. 31-67. Each<span style='letter-spacing:
.05pt'> </span>of<span style='letter-spacing:.05pt'> </span>these<span
style='letter-spacing:.05pt'> </span>paragraphs<span style='letter-spacing:
.05pt'> </span>is<span style='letter-spacing:.05pt'> </span>addressed<span
style='letter-spacing:.05pt'> </span>to<span style='letter-spacing:.05pt'> </span>a<span
style='letter-spacing:.05pt'> </span>different<span style='letter-spacing:.05pt'>
</span>term<span style='letter-spacing:.05pt'> </span>used<span
style='letter-spacing:.05pt'> </span>within<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>corresponding description.<span
style='letter-spacing:.05pt'> </span>The most logical reading in context is
that the<span style='letter-spacing:.05pt'> </span>patentee intended to
elaborate on the specific embodiment referenced two<span style='letter-spacing:
.05pt'> </span>paragraphs<span style='letter-spacing:.05pt'> </span>earlier.<span
style='letter-spacing:.05pt'> </span>The<span style='letter-spacing:.05pt'> </span>court<span
style='letter-spacing:.05pt'> </span>also<span style='letter-spacing:.05pt'> </span>finds<span
style='letter-spacing:.05pt'> </span>it<span style='letter-spacing:.05pt'> </span>significant<span
style='letter-spacing:3.35pt'> </span>that<span style='letter-spacing:3.4pt'> </span>the<span
style='letter-spacing:3.35pt'> </span>claims<span style='letter-spacing:.05pt'>
</span>clearly<span style='letter-spacing:2.65pt'> </span>contemplate<span
style='letter-spacing:2.65pt'> </span>mRNA<span style='letter-spacing:2.7pt'> </span>open<span
style='letter-spacing:2.4pt'> </span>reading<span style='letter-spacing:2.7pt'>
</span>frames,<span style='letter-spacing:2.65pt'> </span><i style='mso-bidi-font-style:
normal'>see,<span style='letter-spacing:2.65pt'> </span>e.g.</i>,<span
style='letter-spacing:2.7pt'> </span><i style='mso-bidi-font-style:normal'>id.</i>,<span
style='letter-spacing:2.65pt'> </span>cl.<span style='letter-spacing:2.7pt'> </span>1,<span
style='letter-spacing:2.65pt'> </span>and</p>

</div>

<span style='font-size:11.0pt;line-height:200%;font-family:"Georgia",serif;
mso-fareast-font-family:Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span>

<div class=WordSection15>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:12.9pt;margin-right:40.9pt;margin-bottom:
0in;margin-left:40.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;line-height:200%'>that the specification contains repeated
references to such open reading<span style='letter-spacing:.05pt'> </span>frames,<span
style='letter-spacing:.05pt'> </span><i style='mso-bidi-font-style:normal'>see,
e.g., id.</i>, col.<span style='letter-spacing:.05pt'> </span>4, ll. 48-56; <i
style='mso-bidi-font-style:normal'>id.</i>,<span style='letter-spacing:.05pt'> </span>col.<span
style='letter-spacing:.05pt'> </span>5, ll. 10-20 <i style='mso-bidi-font-style:
normal'>id.</i>,<span style='letter-spacing:3.35pt'> </span>col. 7, ll.<span
style='letter-spacing:3.4pt'> </span>14-<span style='letter-spacing:.05pt'> </span>18;
<i style='mso-bidi-font-style:normal'>id.</i>, col. 9, ll. 23-29.<span
style='letter-spacing:.05pt'> </span>It would make little sense to claim or
describe<span style='letter-spacing:.05pt'> </span>mRNA open reading frame
embodiments if the patentee meant for open<span style='letter-spacing:.05pt'> </span>reading<span
style='letter-spacing:.6pt'> </span>frame<span style='letter-spacing:.45pt'> </span>to<span
style='letter-spacing:.45pt'> </span>be<span style='letter-spacing:.6pt'> </span>confined<span
style='letter-spacing:.6pt'> </span>to<span style='letter-spacing:.55pt'> </span>the<span
style='letter-spacing:.45pt'> </span>DNA<span style='letter-spacing:.65pt'> </span>context.<a
href="#_bookmark13"><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:200%;color:windowtext;position:relative;top:-3.5pt;mso-text-raise:
3.5pt;text-decoration:none;text-underline:none'>14</span></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:200%'><o:p></o:p></span></p>

<h1 style='margin-right:147.9pt'>ORDER</h1>

<p class=MsoBodyText style='margin-top:.45pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:41.0pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:35.95pt;line-height:200%'>The<span
style='letter-spacing:3.35pt'> </span>claim terms at issue will be construed
for the jury and for all<span style='letter-spacing:.05pt'> </span>other
purposes in the pending litigation in a manner consistent with the<span
style='letter-spacing:.05pt'> </span>above<span style='letter-spacing:.35pt'> </span>rulings<span
style='letter-spacing:.55pt'> </span>of<span style='letter-spacing:.5pt'> </span>the<span
style='letter-spacing:.5pt'> </span>court.</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:255.95pt;margin-bottom:.0001pt'><span class=GramE>SO</span><span
style='letter-spacing:.95pt'> </span>ORDERED.</p>

<p class=MsoBodyText><span style='font-size:16.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:13.55pt;margin-right:0in;margin-bottom:
0in;margin-left:255.95pt;margin-bottom:.0001pt'><u>/s/<span style='letter-spacing:
.85pt'> </span>Richard<span style='letter-spacing:.55pt'> </span>G.<span
style='letter-spacing:.85pt'> </span>Stearns</u>____________</p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:255.95pt;margin-bottom:.0001pt'>UNITED<span style='letter-spacing:
1.3pt'> </span>STATES<span style='letter-spacing:1.15pt'> </span>DISTRICT<span
style='letter-spacing:1.2pt'> </span>JUDGE</p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.45pt'><!--[if gte vml 1]><o:wrapblock><v:rect
  id="docshape40" o:spid="_x0000_s2050" style='position:absolute;margin-left:1in;
  margin-top:13.65pt;width:2in;height:.7pt;z-index:-15724544;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' fillcolor="black" stroked="f">
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:rect><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=96 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=192 height=1
   src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image001.gif" v:shapes="docshape40"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:10.5pt;mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:6.45pt;margin-right:40.8pt;margin-bottom:
0in;margin-left:39.95pt;margin-bottom:.0001pt;text-align:justify;text-justify:
inter-ideograph;text-indent:.5in'><a name="_bookmark13"></a><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;position:relative;top:-3.5pt;
mso-text-raise:3.5pt'>14 </span>Although case law is clear that courts may not
redraft claims . . . to<span style='letter-spacing:.05pt'> </span>make them
operable or to sustain their validity, this situation is not one in<span
style='letter-spacing:.05pt'> </span>which<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>claim<span style='letter-spacing:.05pt'> </span>language<span
style='letter-spacing:.05pt'> </span>itself<span style='letter-spacing:.05pt'> </span>(or<span
style='letter-spacing:.05pt'> </span>even<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span>relevant<span style='letter-spacing:.05pt'>
</span>portion<span style='letter-spacing:.05pt'> </span>of<span
style='letter-spacing:.05pt'> </span>the<span style='letter-spacing:.05pt'> </span>specification)
unambiguously dictates one interpretation. <i style='mso-bidi-font-style:normal'>Cf.
Chef Am., Inc.<span style='letter-spacing:-3.25pt'> </span>v.<span
style='letter-spacing:-.05pt'> </span>Lamb-Weston, Inc.</i>,<span
style='letter-spacing:-.15pt'> </span>358 F.3d<span style='letter-spacing:-.05pt'>
</span>1371,<span style='letter-spacing:-.15pt'> </span>1373<span
style='letter-spacing:-.1pt'> </span>(Fed. Cir.<span style='letter-spacing:
-.05pt'> </span>2004).</p>

</div>

<span style='font-size:11.0pt;font-family:"Georgia",serif;mso-fareast-font-family:
Georgia;mso-bidi-font-family:Georgia;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always;
mso-break-type:section-break'>
</span>

<div class=WordSection16>

<p class=MsoNormal style='margin-top:3.0pt;margin-right:0in;margin-bottom:0in;
margin-left:6.25pt;margin-bottom:.0001pt'><span class=SpellE><span
style='font-size:9.5pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia;mso-font-width:105%'>ModernaTX</span></span><span
style='font-size:9.5pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia;mso-font-width:105%'>,<span
style='letter-spacing:-.5pt'> </span>Inc.<span style='letter-spacing:-.5pt'> </span>et<span
style='letter-spacing:-.45pt'> </span>al<span style='letter-spacing:-.5pt'> </span>v.<span
style='letter-spacing:-.5pt'> </span>Pfizer<span style='letter-spacing:-.45pt'>
</span>Inc.<span style='letter-spacing:-.5pt'> </span>et<span style='letter-spacing:
-.5pt'> </span>al,<span style='letter-spacing:-.45pt'> </span>Docket<span
style='letter-spacing:-.5pt'> </span>No.<span style='letter-spacing:-.5pt'> </span>1:22-cv-11378<span
style='letter-spacing:-.45pt'> </span>(D.<span style='letter-spacing:-.5pt'> </span>Mass.<span
style='letter-spacing:-.45pt'> </span>Aug<span style='letter-spacing:-.5pt'> </span>26,<span
style='letter-spacing:-.5pt'> </span>2022),<span style='letter-spacing:-.45pt'>
</span>Court<span style='letter-spacing:-.5pt'> </span>Docket</span><span
style='font-size:9.5pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p></o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.1pt'><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:147.75pt;
margin-bottom:0in;margin-left:146.9pt;margin-bottom:.0001pt;text-align:center'><b
style='mso-bidi-font-weight:normal'><span style='font-size:21.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>General Information<o:p></o:p></span></b></p>

<p class=MsoBodyText><b style='mso-bidi-font-weight:normal'><span
style='font-size:21.0pt;mso-bidi-font-size:14.0pt;font-family:"Arial",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoBodyText><b style='mso-bidi-font-weight:normal'><span
style='font-size:21.0pt;mso-bidi-font-size:14.0pt;font-family:"Arial",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoBodyText style='margin-top:.25pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:22.0pt;mso-bidi-font-size:14.0pt;font-family:
"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-left:5.5pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Case<span style='letter-spacing:-.05pt'> </span>Name<span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
class=SpellE><span style='font-size:12.0pt;mso-bidi-font-size:11.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'>ModernaTX</span></span><span style='font-size:
12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>,<span
style='letter-spacing:.1pt'> </span>Inc.<span style='letter-spacing:.05pt'> </span>et<span
style='letter-spacing:.1pt'> </span>al<span style='letter-spacing:.1pt'> </span>v.<span
style='letter-spacing:.05pt'> </span>Pfizer<span style='letter-spacing:.1pt'> </span>Inc.<span
style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.1pt'> </span>al<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.15pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:5.5pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Court<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>U.S.<span
style='letter-spacing:.05pt'> </span>District<span style='letter-spacing:.05pt'>
</span>Court<span style='letter-spacing:.05pt'> </span>for<span
style='letter-spacing:.1pt'> </span>the<span style='letter-spacing:.05pt'> </span>District<span
style='letter-spacing:.05pt'> </span>of<span style='letter-spacing:.1pt'> </span>Massachusetts<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.2pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:5.5pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Date Filed<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>Fri<span
style='letter-spacing:.05pt'> </span>Aug<span style='letter-spacing:.1pt'> </span>26<span
style='letter-spacing:.1pt'> </span>00:00:00<span style='letter-spacing:.05pt'>
</span>EDT<span style='letter-spacing:.1pt'> </span>2022<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.15pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:5.5pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Judge(s)<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>RICHARD<span
style='letter-spacing:.05pt'> </span>GAYLORE<span style='letter-spacing:.1pt'> </span>STEARNS<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.15pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:0in;
margin-left:5.5pt;margin-bottom:.0001pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Federal Nature<span style='letter-spacing:-.05pt'> </span>of Suit<span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>Property<span
style='letter-spacing:.1pt'> </span>Rights:<span style='letter-spacing:.1pt'> </span>Patent<span
style='letter-spacing:.05pt'> </span>[830]<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.15pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:5.5pt;tab-stops:156.95pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Docket<span style='letter-spacing:-.05pt'> </span>Number<span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>1:22-cv-11378<o:p></o:p></span></p>

<p class=MsoBodyText style='margin-top:.15pt'><span style='font-size:17.5pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:.05pt;margin-right:19.05pt;margin-bottom:
0in;margin-left:157.0pt;margin-bottom:.0001pt;text-indent:-151.5pt;line-height:
126%;tab-stops:156.95pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:126%;font-family:
"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'>Parties<span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span
style='font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:126%;font-family:
"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>Pfizer<span style='letter-spacing:.05pt'> </span>Inc.;<span
style='letter-spacing:.05pt'> </span>BioNTech<span style='letter-spacing:.05pt'>
</span>SE;<span style='letter-spacing:.05pt'> </span>BioNTech<span
style='letter-spacing:.05pt'> </span>US<span style='letter-spacing:.05pt'> </span>Inc.;<span
style='letter-spacing:.05pt'> </span>BioNTech<span style='letter-spacing:.05pt'>
</span>Manufacturing<span style='letter-spacing:-3.05pt'> </span>GmbH;<span
style='letter-spacing:.1pt'> </span>Moderna<span style='letter-spacing:.1pt'> </span>US,<span
style='letter-spacing:.1pt'> </span>Inc.;<span style='letter-spacing:.1pt'> </span><span
class=SpellE>ModernaTX</span>,<span style='letter-spacing:.1pt'> </span>Inc.<o:p></o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText><span style='font-size:10.0pt;mso-bidi-font-size:14.0pt;
font-family:"Microsoft Sans Serif",sans-serif;mso-hansi-font-family:Georgia;
mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoBodyText style='margin-top:.5pt'><span style='font-size:11.0pt;
mso-bidi-font-size:14.0pt;font-family:"Microsoft Sans Serif",sans-serif;
mso-hansi-font-family:Georgia;mso-bidi-font-family:Georgia'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:4.75pt;margin-right:0in;margin-bottom:
0in;margin-left:267.3pt;margin-bottom:.0001pt'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="image1.jpeg" o:spid="_x0000_s2059" type="#_x0000_t75"
 style='position:absolute;left:0;text-align:left;margin-left:38.15pt;
 margin-top:5.75pt;width:150.55pt;height:22.05pt;z-index:15733248;visibility:visible;
 mso-wrap-style:square;mso-wrap-distance-left:0;mso-wrap-distance-top:0;
 mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text'>
 <v:imagedata src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image003.jpg"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
absolute;z-index:15733248;left:0px;margin-left:51px;margin-top:8px;width:201px;
height:29px'><img width=201 height=29
src="Moderna-v-Pfizer-DCT-Claim-Construction_files/image004.jpg" v:shapes="image1.jpeg"></span><![endif]><span
style='font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;
mso-bidi-font-family:Georgia'>&copy; 2023 Bloomberg Industry Group, Inc. All Rights
Reserved.<span style='letter-spacing:-.05pt'> </span></span><a
href="https://www.bloombergindustry.com/customer-agreement/"><span
style='font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;
mso-bidi-font-family:Georgia;color:blue'>Terms of Service</span></a><span
style='font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;
mso-bidi-font-family:Georgia'><o:p></o:p></span></p>

<p class=MsoNormal align=right style='margin-top:3.9pt;margin-right:4.9pt;
margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right'><b
style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-hansi-font-family:Georgia;mso-bidi-font-family:
Georgia'>// PAGE 16<o:p></o:p></span></b></p>

</div>

</body>

</html>
